Journal of Men's Health,2025,21(6):1-20 DOI:10.22514/jomh.2025.076
Review

Efficacy and putative mechanisms of action of nutraceuticals in the management of erectile dysfunction: a narrative review

Lorenzo Romano1,2,*,,, Michele Musone3,*,,, Luigi Napolitano3, Lorenzo Spirito1, Celeste Manfredi1, Davide Arcaniolo1, Ferdinando Fusco4, Biagio Barone5, Antonio Tufano6, Pier Paolo Prontera7, Ugo Amicuzi3, Antonio Cioffi2, Ciro Imbimbo3, Marco De Sio1, Carmine Sciorio8, Felice Crocetto3

1Department of Woman, Child and General and Specialized Surgery and Urology Unit, University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy

2Urology Unit, Ospedale del Mare General Hospital, 80147 Naples, Italy

3Department of Neurosciences, Reproductive Sciences and Odontostomatology and Urology Unit, Federico II University, 80131 Naples, Italy

4Division of Urology, Department of Surgical Sciences, AORN Sant’Anna e San Sebastiano, 81100 Caserta, Italy

5Department of Urology, Ospedale San Paolo General Hospital ASL NA1 Centro, 80125 Naples, Italy

6Urology Unit, National Institute of Cancer, IRCCS Foundation G Pascale, 80131 Naples, Italy

7Department of Urology, “S.S. Annunziata” Hospital, 74121 Taranto, Italy

8Urology Unit, Alessandro Manzoni General Hospital, 23900 Lecco, Italy

*Corresponding Author(s):lorenzo.romano@unicampania.it (Lorenzo Romano); michele.musone@unina.it (Michele Musone)

† These authors contributed equally.

History Submitted: 20 March 2025 | Accepted: 06 May 2025 | Published: 30 June 2025
Copyright:  ©2025  The Author(s). Published by MRE Press.
This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).

Collapse table of contents

Abstract

Erectile dysfunction (ED) is a common condition in the male population and is influenced by numerous pathophysiological factors. Recently, interest in nutraceuticals and natural remedies as complementary or alternative therapies to traditional pharmacological treatments has increased exponentially. This narrative review aims to analyze the impact of the most studied nutraceuticals in the treatment of ED, analyzing their mechanisms of action, clinical efficacy and safety. Much attention has been paid to compounds such as L-arginine, as well as several medicinal plants including ginseng, maca, Tribulus terrestris and antioxidant substances such as resveratrol and Pycnogenol. These natural products have different mechanisms of action, including modulation of endothelial function, reduction of oxidative stress and balance of sex hormones, thus addressing multiple therapeutical targets for the management of ED. However, despite promising results reported in various preclinical and clinical studies, several limitations to the use of nutraceuticals for ED persist, including variability in study designs, lack of standardized dosages of various compounds and lack of long-term safety evaluations. In fact, although nutraceuticals generally demonstrate a favorable safety profile compared to traditional drugs, they are not completely exempt from possible side effects. Furthermore, issues such as inconsistent patient adherence to treatment and potential interactions with drug therapies require further research and investigation. Therefore, high-quality, adequately sized clinical trials to better evaluate the efficacy and safety of these compounds, alone or in combination with conventional, widely adopted therapeutic regimens are warranted. In conclusion, nutraceuticals present a promising therapeutic option in the management of ED, potentially capable of improving clinical outcomes and patients’ quality of life when integrated into an all-inclusive therapeutic strategy.

Keywords:Erectile dysfunction;Nutraceuticals;Herbal medicines;Dietary supplements;Antioxidants
PDF(678.99 kB)|EndNote (RIS)|BibTeX|RefMan|RefWorks

Cite this article

Lorenzo Romano, Michele Musone, Luigi Napolitano, Lorenzo Spirito, Celeste Manfredi, Davide Arcaniolo, et al.Efficacy and putative mechanisms of action of nutraceuticals in the management of erectile dysfunction: a narrative review.Journal of Men's Health,2025,21(6):1-20 DOI:10.22514/jomh.2025.076

1. Introduction

Erectile dysfunction (ED) is defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual intercourse. ED is a particularly common condition affecting an increasing number of men worldwide, with the prevalence increasing progressively with age: in fact, it is estimated that about 52% of men aged 40–70 years’ experience some form of ED, with the prevalence increasing from about 20% at age 40 to 70% in men aged 70 years and older [1]. The prevalence of ED appears to be influenced by several factors including socioeconomic factors, lifestyle and pre-existing comorbidities such as diabetes, hypertension, hepato-gastroenterological disease and cardiovascular disease [2, 3, 4, 5, 6]. Indeed, the literature reports that about 20% of men with diabetes mellitus (DM) suffer from ED, a condition that is often difficult to treat because of diabetes-related vascular and nerve damage [7]. Traditionally, the treatment of ED has focused almost entirely on phosphodiesterase type 5 inhibitors (PDE5i) such as sildenafil, tadalafil and vardenafil, and later on, on the use of mechanical devices such as penile prostheses, as well as hormonal modulation [8]. PDE5i by specifically improving peripheral vasodilation through the inhibition of PDE5, represent the most widely used strategy for the treatment of ED, however their use has a number of limitations. In fact, there are many side effects related to the use of this class of drugs among which the most common ones include headache, dyspepsia, nasal congestion and, in some cases, even severe effects such as loss of vision or hearing [9]. Moreover, not all patients respond adequately to these drugs, particularly those with ED caused by psychological problems or comorbidities such as DM [10]. Additional factors that limit the use of these drugs are their high cost, and the variable adherence to treatment by patients. Hence, the interest in natural and complementary alternatives to traditional drugs [11, 12].

Mounting evidence supports the concept that products isolated or purified from foods can exert biological activity with physiological benefits in numerous chronic diseases; these products when provided in medicinal form are referred to as nutraceuticals (i.e., bioactive products extracted from foods or natural compounds that fit into the gap between nutrition and pharmaceuticals) [13]. Nutraceuticals have proven to be a promising alternative or even, in some cases, a complementary treatment for ED [11, 12, 14]. While conventional therapies target specific pathophysiological mechanisms, nutraceuticals may act on various biological processes, including modulation of endothelial function, reduction of oxidative stress and regulation of sex hormones [14]. The use of nutraceuticals to treat ED is not completely new. In fact, many traditional medicines, such as Chinese medicine, have always used natural remedies to improve male sexual health. Several scientific studies more recently, have begun to more consistently and thoroughly explore the efficacy of these compounds, thus highlighting the need for further research to determine optimal dosages and long-term safety and providing a comprehensive overview of their mechanisms of action and gaps in scientific research [15, 16, 17, 18]. This review aims to integrate this knowledge to provide a comprehensive overview on the impact that nutraceuticals may have in the management of ED.

2. Methodology

A review of the literature was performed in order to evaluate the clinical efficacy and mechanism of action of herbal phytochemicals and/or other nutrients used for the management of ED. We searched three databases (Google Scholar, Scopus and PubMed) to identify clinical studies addressing the therapeutic role of herbal medicines in ED as well as preclinical studies evaluating the mechanism of action in the past 20 years. No language restriction was applied. The key terms used for the search were male sexual dysfunction, erectile dysfunction, impotence, phytochemical, botanicals, herbal extract, nutraceutical, dietary supplement and traditional medicine. Review articles (i.e., narrative or systematic review and/or meta-analysis), book chapters and original scientific papers on humans were included in our search. We also included experimental studies in animals which explored the putative mechanism of action of a given compound. Abstracts or Meeting proceedings were excluded.

3. Pathophysiology of ED

ED is a multifactorial condition in which the alteration of various physiological and psychological mechanisms may play a causative role [1]. To understand how nutraceuticals can positively influence ED, it is necessary to first explore the key underlying processes that contribute to its development, thereby investigating all causes and concomitant causes leading to this condition. One of the main factors contributing to the pathogenesis of ED is endothelial dysfunction. The ability to achieve and especially maintain a satisfactory erection is highly dependent on the vascular system and its good health, and, in particular, on the release of nitric oxide (NO) from endothelial cells at the level of the corpora cavernosa of the penis [19]. NO acts as a crucial mediator, stimulating the production of cyclic guanosine monophosphate (cGMP), which relaxes the smooth muscle tissue of the cavernous sinusoids and allows the penile blood vessels to dilate, thereby increasing vascular inflow and thus enabling penile tumescence. This mechanism, however, is often impaired in individuals with ED due to endothelial dysfunction, which results in a major reduction in NO availability that consequently reduces the ability of cavernous sinusoids to dilate [20]. Several nutraceuticals such as L-arginine and Panax ginseng have been shown to promote NO production and improve vascular health, thereby mitigating some of the effects of endothelial damage and allowing greater vasodilation at the cavernous level [21, 22]. However, one must keep in mind that these products may represent a serious problem for consumers because of the lack of clear regulations [23].

Another significant factor to consider in the pathophysiology of ED is increased oxidative stress. The accumulation of reactive oxygen species (ROS) can in fact, severely damage endothelial cells, further impairing their ability to produce NO [24]. In addition, oxidative stress also contributes to systemic inflammation, which aggravates vascular remodeling and can also lead to the development of fibrosis in penile tissue, thus reducing its flexibility and function [25]. Several nutraceuticals such as flavonoids, Ginseng and Pycnogenol, characterized by potent antioxidant properties, have been shown to counteract oxidative damage and help restore normal endothelial activity, thus proving as valuable therapeutical tools in the management of ED [21, 26, 27, 28, 29].

Moreover, hormonal imbalance, particularly the reduction in testosterone levels [30], plays a crucial role in the development of ED. This hormone, in fact, is essential for maintaining libido and facilitating the physiological processes of erection [31]. Aging, but also obesity and metabolic syndrome are common causes of low testosterone levels, frequently observed as comorbidities in ED patients [32, 33, 34]. Some nutraceuticals, including Tribulus terrestris and Maca, are well known for their ability to regulate testosterone production and improve libido and hence sexual function, and these properties can be attributed to their ability to increase androgen receptor sensitivity and promote optimal hormone balance [35].

Finally, psychological factors often exacerbate the physical and organic difficulties associated with ED [36]. In fact, conditions such as anxiety, depression and chronic stress are not only common in individuals with ED, but can also create a self-perpetuating cycle that worsens the condition over time by amplifying the sexual dysfunction in these patients [36]. Therefore, addressing psychological aspects is essential for a comprehensive management of ED. Again, several nutraceuticals such as Ashwagandha and Ginseng, have the potential of reducing stress and improving overall mental well-being, thus leading to improved erectile function, particularly in cases where psychogenic factors are present [21, 22, 37].

In summary, ED is contributed to by a combination of vascular, hormonal, oxidative, circulatory and psychological factors. The therapeutic potential of nutraceuticals lies in their ability to specifically target these mechanisms, thus offering a complementary approach to traditional treatments (Fig. 1).

Graphical representation of main mechanisms 
underlying erectile dysfunction and nutraceuticals’ targets of intervention. NO: 
nitric oxide; PDE5: phosphodiesterase type 5.

Fig. 1.Graphical representation of main mechanisms underlying erectile dysfunction and nutraceuticals’ targets of intervention. NO: nitric oxide; PDE5: phosphodiesterase type 5.

4. Nutraceuticals and their role in ED

Nutraceuticals are bioactive substances that come from foods, medicinal plants and natural supplements and are known to offer various therapeutic benefits in a number of chronic pathologic conditions. In addition, these compounds are often safer than traditional drugs, with fewer side effects and a better tolerability profile [38, 39]. In this review, we will examine in detail the main nutraceuticals currently used for ED, thoroughly exploring their mechanisms of action and evaluating the available scientific evidence on their true potential.

4.1 Ginseng (Panax ginseng)

Among the most extensively studied nutraceuticals, Ginseng occupies a prominent place for the treatment of ED due to its pronounced endothelial vasodilation properties as well as the reduction of oxidative stress produced by ginsenosides, the main bioactive metabolites of Ginseng [40]. In fact, ginsenosides, due to the production of NO in the vascular endothelium, improve penile blood flow and modulate neurotransmitter release, further supporting erectile function [21]. In addition, due to their anti-inflammatory and antioxidant effects they protect endothelial cells from oxidative damage [21]. About 20 clinical and preclinical studies have been conducted on mild-to-moderate ED patients treated with ginsenosides, and in these studies, an average improvement of 3–5 points in the International Index of Erectile Function (IIEF) was reported [41]. In particular, a randomized trial of patients with mild-to-moderate ED showed significant benefits with respect to erectile stiffness, duration of erection and libido [42]. Of particular interest, in a systematic review, Lee et al. [43] found that Ginseng had a trivial effect on ED when compared to a placebo, based on the Erectile Function Domain of the IIEF-15, i.e., (mean difference of about 3 points compared to a placebo) with little or no side effects [43]. Nevertheless, standardization of dosages and confirmation of long-term efficacy require further studies.

4.2 Tribulus terrestris

Tribulus terrestris is a compound that has traditionally been used as an aphrodisiac. In fact, this plant modulates hormone levels, specifically increasing testosterone production and androgen receptor sensitivity through its active compound, namely protodioscin [44]. Tribulus terrestris has been analyzed in several studies reporting improvements of 2–4 points at IIEF, with effects more pronounced in men with ED related to hormonal imbalances than in those with ED of vascular origin [45]. In particular, Kamenov et al. [45] evaluated the efficacy and safety of a standardized extract (Tribestan®, Sopharma AD-coated tablets containing 250 mg of dry extract equivalent to furostanol saponins not less than 112.5 mg) for the treatment of men with mild to moderate ED and with or without hypoactive sexual desire disorder in a prospective, phase IV, randomized, double-blind, placebo controlled clinical trial in parallel groups. The authors showed a significant improvement in erection, libido and orgasmic function in the treated group, in the absence of any difference in the profile of side effects as compared with the placebo [45]. On the other hand, Santos et al. [46] in a prospective, randomized, double-blind study of patients with ED found that patients treated with 400 mg of Tribulus terrestris extract reported no significant benefit compared to the placebo group [46]. While one case of nephrotoxicity and another of increase in serum bilirubin levels have been described, no clinical trial in which Tribulus terrestris-based products were administered, have reported these side effects.

4.3 Maca (lepidium meyenii)

Maca is a Peruvian root known for its aphrodisiac properties [47, 48]. Several clinical trials have been performed on healthy men and patients with ED, showing significant improvements in libido and sexual satisfaction in both patient groups [48]. In particular, Maca has important potential as an adjuvant therapy to improve overall sexual health [48]. Maca has been shown to exert a modest impact on IIEF scores, with improvements of 1–2 points, the more significant effects being on libido and sexual satisfaction [49]. The safety profile is favorable with only mild gastrointestinal disturbances reported by few patients [49]. The properties of Maca are mainly due to its bioactive compounds, including alkaloids and flavonoids, which influence hormonal balance and improve mitochondrial energy production [50]. Its efficacy in patients with comorbidities such as obesity or diabetes and its potential for synergistic effects with other interventions are yet to be determined.

4.4 Epimedium (horny goat weed)

Epimedium, otherwise known as Horny Goat Weed, is a compound particularly well known for its use in ED. Its bioactive components, flavonoids and prenylhydroquinones are potent PDE5i, similar to sildenafil, one of the main drugs used to treat ED [51, 52]. Epimedium has been analyzed in several clinical studies showing modest improvements of 2–3 points at IIEF, particularly in combination with antioxidants that synergistically enhance the vasodilating capability of Horny Goat Weed [53, 54]. However, further research is needed to address issues such as long-term outcomes and potential anti-inflammatory properties, as well as combination strategies with other nutraceuticals to enhance its efficacy.

4.5 Yohimbine (extracted from pausinystalia yohimbe)

Pausinystalia yohimbe extract, Yohimbine, is an alkaloid that behaves as an antagonist of pre-synaptic alpha-2-adrenergic receptors, thereby promoting blood vessel relaxation and increasing blood flow in the penis. Moreover, Yohimbine, is able to enhance sexual arousal through central nervous system (CNS) stimulation thus proving efficacy in the treatment of psychogenic ED [55]. Controlled clinical trials have shown significant 2–3 point improvements in IIEF score in patients treated with Yohimbine compared with placebos, although side effects (e.g., hypertension and anxiety) may limit its use [56, 57, 58]. Future research directions should be aimed at optimizing dosing regimens to mitigate adverse effects and explore its use in combination with anxiolytics.

4.6 Saffron (crocus sativus)

The main active compounds in Saffron, crocin and safranal, exert neuroprotective and antioxidant effects, improving both psychological and physiological factors involved in ED [59]. Saffron seems particularly useful in ED associated with stress or depression, by improving penile rigidity and sexual satisfaction [60]. Saffron has been evaluated in several clinical studies and results consistently show an average IIEF improvement of 3 to 4 points after four weeks of treatment [61, 62]. Also, Saffron has shown a favorable safety profile without major adverse events [59] Future research should assess its potential therapeutic role in combination therapies for patients with psychological comorbidities.

4.7 L-arginine

L-arginine is an essential amino acid that acts as a precursor of NO, a key mediator of vasodilation and physiologic endothelial function [63]. Supplementation with L-arginine increases the bioavailability of NO, and numerous clinical studies have shown that combining L-arginine with antioxidants (e.g., Pycnogenol) consistently improves erectile function in patients with vascular ED, with an improvement in IIEF of about 3–6 points [64, 65]. It should be specified, however, that L-arginine monotherapy produces less consistent results, compared with combination therapy depending on the dose and duration of administration [66, 67, 68]. Best results were obtained by administering 6–8 g/day for periods of time ranging from 3 to 6 months [67, 68]. Overall, L-arginine is safe and well-tolerated, suggesting that it might be an alternative treatment in mild-moderate vasculogenic ED patients with adverse effects or contraindications for chronic treatment with PDE5i. It should be used with caution in patients on nitrate therapy.

4.8 Pycnogenol (maritime pine bark extract)

Pycnogenol, a derivative of Maritime pine bark, is a potent antioxidant that improves endothelial function and reduces oxidative stress [69]. It is normally used in synergy with L-arginine, increasing NO production, enhancing vasodilation and consequently promoting erectile activity [64, 65]. Clinical studies involving patients with moderate ED demonstrated that the combination of L-arginine and Pycnogenol significantly improved the quality of erection within three months of therapy and with no significant side effects, leading to an increase in IIEF scores of 3–6 points [64, 65]. Future research should focus on evaluating its long-term safety profile and efficacy in diverse patient populations.

4.9 Ashwagandha (withania somnifera)

Ashwagandha is an adaptogenic compound known for its ability to improve stress response and promote hormonal balance [70]. These effects may have a positive impact on libido and erectile function, particularly in men with psychogenic ED. Furthermore, it has been shown to increase testosterone levels, further supporting libido and erectile function [70, 71]. Several studies have explored the role of Ashwagandha in ED, particularly in psychogenic cases [70, 71], whereby showing improvements in IIEF scores of 1–3 points. In particular, in an 8-week randomized, double-blind, placebo-controlled study Ashwagandha root extract at a dose of 300 mg twice daily in adult males with psychogenic ED was shown to exert significant improvement of sexual desire without any significant side effect [71]. Furthermore, Ashwagandha helps reducing cortisol levels, thereby alleviating stress, a key contributing factor to psychogenic ED, and improves sperm quality, testosterone, levels and libido [72]. However, its specific effects on erectile function require further research. In particular, its long-term clinical impact should be better clarified as well as whether combinations with anxiolytics or PDE5i may offer a more complete solution for patients with complex cases of ED with relevant psychological components [72].

4.10 Ginkgo biloba

Ginkgo biloba, a compound known to improve blood circulation due to its vasodilatory effects, acts as a modulator of NO thus ensuring greater blood flow to the corpora cavernosa of the penis [73, 74]. Moreover, the antioxidant properties of Ginkgo biloba help reduce oxidative stress, a common factor in ED of vascular origin [74]. Ginkgo biloba seems particularly useful in cases of ED caused by circulatory disorders or by the use of antidepressants. In fact, Gingko biloba has shown particular efficacy in cases of ED induced by the use of selective serotonin reuptake inhibitors (SSRIs), with patients reporting an improvement in erectile rigidity and overall sexual satisfaction with IIEF improvements ranging from 2 to 4 points [75, 76]. Despite these benefits, more extensive and standardized studies are needed to establish its long-term safety and optimal dosage, and whether it can be integrated with conventional therapies such as PDE5i. In this regard, a recent study has shown that a nutraceutical combination of Gingko biloba with alpha lipoic acid and Vitis vinifera L given for three months in association with Avanafil significantly increased sexual performance in 123 males with type 2 DM-associated ED, without any significant adverse event [77].

4.11 L-citrulline

L-citrulline is a precursor to NO similar to L-arginine. However, while the latter’s efficacy can be limited by rapid metabolism, L-citrulline has better bioavailability and is rapidly converted into L-arginine [78, 79]. Studies show significant improvements in erection rigidity with L-arginine and L-citrulline administration, especially when combined with other compounds like Pycnogenol [65, 79], with an increase in IIEF score of 3 to 5 points. In a single-blind study involving patients with mild ED, L-citrulline supplementation significantly increased erection hardness and number of intercourses per month [78]. Because of its superior bioavailability when compared with L-arginine, L-citrulline offers a more effective option for sustained NO production [80].

4.12 Anti-oxidants

Oxidative stress plays a major role in causing vascular endothelial dysfunction which may in turn lead to ED. Therefore, natural compounds with anti-oxidant properties have been regarded to as possible therapeutic agents in this clinical setting. Resveratrol, a nonflavonoid polyphenol, improves endothelial function and reduces oxidative stress [81]. Significant benefits have been observed in cardiovascular health, indirectly linked to ED [81, 82]. It has been shown that resveratrol may provide modest benefits in ED management [82, 83], with IIEF score improvements averaging 2 to 3 points [82, 83]. Resveratrol’s cardiovascular benefits also suggest its potential as a preventive strategy for ED linked to metabolic syndrome or other vascular conditions [81]. While resveratrol can be regarded to as a safe agent without major adverse events linked to its use, the optimal dosage, long-term effects, and potential interactions with medications still need to be investigated through well-designed randomized controlled trials (RCTs). Flavonoids, found in abundance in cocoa and green tea, have also demonstrated significant promise in the treatment of ED by improving endothelial function and reducing oxidative stress [84, 85]. The use of these compounds has been associated with moderate increases in IIEF score, typically ranging from 2 to 4 points. By enhancing NO bioavailability and promoting vasodilation, flavonoids offer a natural and potentially preventive approach to managing ED, particularly in vascular-related cases [85, 86].

4.13 Vitamins C and E

Vitamins C and E are antioxidants capable of counteracting ROS, thereby improving vascular health [87]. These compounds have been the subject of numerous studies showing improvements of varying degrees in erectile function [88]. In particular, vitamins C and E have been shown to yeild modest improvements in IIEF scores of approximately 1–2 points. However, although their efficacy as monotherapy is limited, they have demonstrated synergistic effects when combined with other nutraceuticals, such as L-arginine or Pycnogenol [89]. Future research for the treatment of ED should focus on optimizing these combinations to increase their therapeutic potential.

4.14 Omega-3 fatty acid

Omega-3 fatty acids reduce systemic inflammation and improve the fluidity of cell membranes, thus enhancing vascular signaling and consequently increasing the endothelial compliance of the cavernous sinusoids [90]. Observational studies indicate a positive association between omega-3 consumption and a reduced incidence of ED [91]. Omega-3 fatty acids, known for their anti-inflammatory and vascular benefits, have been the focus a number of studies which have shown only modest improvements in penile rigidity [92]. They are particularly beneficial in ED cases linked to metabolic syndrome or chronic inflammation [91]. More robust clinical trials are needed to establish their efficacy and explore potential synergies with other nutraceuticals.

4.15 Zinc and other micronutrients

Zinc, a vital micronutrient, has also been explored in ED research [93]. Zinc is essential for testosterone synthesis and testicular function maintenance [93] and its deficiency has been correlated with an increased risk of ED [93]. Other micronutrients, such as magnesium and vitamin D, have been found to be essential in hormonal and vascular regulation [94]. Zinc supplementation has shown slight improvements in IIEF scores (1–2 points), mainly in individuals with underlying zinc deficiencies. Zinc supplementation has also been shown to improve hormonal balance and libido, although its effects on erectile function appear to be more pronounced in combination with other therapies [95]. Future research should be focused on zinc-deficient populations and investigate its interactions with other micronutrients, such as magnesium and vitamin D.

4.16 Probiotics and gut microbiota

Recently, much attention has been paid at the connection between gastrointestinal and genitourinary tracts. In particular conditions which alter the composition of gastrointestinal microbiota may affect the lower urinary tract through the mechanism of the pelvic cross-organ sensitization by which an altered gastrointestinal barrier potentially driven by intestinal dysbiosis may negatively affect adjacent organs through the passage of bacteria or bacterial products [96, 97, 98, 99]. While current evidence is preliminary, this area holds great promise for future exploration, particularly in metabolic and vascular-related ED.

Emerging evidence suggests that a “healthy” gut microbiota strongly contributes to normal sexual functioning [100, 101]. In the context of ED, dysbiosis (i.e., an imbalance within gut microbiota community), may lead to systemic inflammation, endothelial dysfunction and hormonal imbalances, all key factors in ED pathogenesis. A decrease in short chain fatty acids production, such as butyrate, may alter gut barrier integrity, and impair endothelial function by promoting inflammation and reducing NO availability [101]. Moreover, the modulation of bile acid metabolism by gut microbiota influences energy balance and immune homeostasis through the interaction with bile acid receptors [101]. Finally, dysbiosis can lead to alterations in neurotransmitter production, immune activation and hypothalamic–pituitary–adrenal axis regulation, potentially affecting mood and stress levels, which are known to influence erectile function. All of these processes are critical in the maintenance of vascular health and in the regulation of sex hormones, both essential for erectile function. Therefore, intestinal dysbiosis may contribute to ED by the alteration of hormone levels, by dysruption of the gut-brain axis leading to stress/anxiety-mediated (i.e., psychogenic) ED, or by influencing the development of altered metabolic conditions such as obesity and diabetes mellitus or hypertension [102]. Therefore, it has been suggested that improving gut health might positively influence endothelial function and reduce systemic inflammation, indirectly benefiting erectile performance [102]. Moreover, it has been demonstrated that in ED there is a decrease in beneficial bacteria such as Alistipes and Bifidobacterium and an increase in harmful bacteria such as Actinomyces and Bacteroides [101]. Based on this, treatment strategies for ED through the modulation of gut microbiota by using specifically designed probiotic/symbiotic formulations or even fecal microbiota transplantation (FMT) represent a promising area of research [101]. It would therefore be crucial to identify specific bacterial strains or microbial metabolites that exert a beneficial effect on erectile function. In this regard, it has been suggested that taxa like Ruminococcaceae and Lactobacillus, as well as metabolites like butyrate may reduce systemic inflammation and improve vascular health, thus positively affecting male sexual function [101]. However, the association between specific gut microbial taxa and ED is derived from cross-sectional studies which do not account for potential confounders such as nutritional status, the use of medication such as antibiotics or gastric acid secretion inhibitors, and comorbidities like obesity, diabetes and hypertension, all of which can affect the gut microbiota composition. Moreover, only a limited number of observational and pilot studies have explored gut microbiota-targeted strategies in ED, and, therefore, well-designed randomized clinical trials are warranted to assess the real efficacy of gut microbiota manipulation in specific types of ED.

4.17 Muira puama

Muira puama (i.e., Ptychopetalum olacoides) is a plant native to the Amazonian regions of Brazil, particularly in rainforest areas. It is traditionally used by Brazilian indigenous populations, and is known for its aphrodisiac and stimulating properties [103]. The name “Muira puama” originates from the local language, with “muira” meaning “strength” or “energy” and “puama” referring to the plant itself [104]. The bark and roots are the parts of the plant primarily used for medicinal purposes, containing a range of bioactive compounds, such as alkaloids, sterols and flavonoids, believed to be responsible for the stimulating effects on sexual function [103, 104]. Muira puama has shown positive effects on libido and quality of erections [105], particularly in cases of psychogenic ED [105]. A few studies have shown improvements in IIEF score of approximately 3–4 points after 8 weeks of treatment with Muira puama, with a significant increase in erectile rigidity and sexual satisfaction [105, 106]. Muira puama primarily acts as a central nervous system stimulant, enhancing sensitivity and sexual response [103]. Its effects are linked to hormonal modulation, which can reduce psychological stress, a key factor in ED [104].

4.18 Cocoa polyphenols

Cocoa polyphenols, especially flavonoids, are known for their positive effects on cardiovascular health and consequently on erectile function, thanks to their ability to increase the bioavailability of NO [107]. There are numerous studies suggesting that the consumption of flavonoid-rich cocoa can improve blood flow and erectile function in patients with ED associated with endothelial dysfunction [108]. In particular, patients with mild ED have been reported to achieve significant improvements in penile rigidity after 4 weeks of treatment with high-flavonoid cocoa [108, 109].

4.19 Reishi (ganoderma lucidum)

Reishi, otherwise known as Ganoderma lucidum, is a medicinal mushroom known for its adaptogenic and antioxidant properties, with beneficial effects on vascular health and consequently on erectile function [110]. Although research on its efficacy in ED is still limited, some clinical studies suggest that Reishi may improve erectile function, especially in cases of vascular or stress-related dysfunction. In fact, the use of Reishi for 12 weeks has been shown to lead to improvements in penile rigidity [111]. The mushroom acts on various fronts in the treatment of ED: on the one hand, by regulating fibrosis and the Nitric Oxide Synthase/Extracellular signal-Regulated Kinase/Janus Kinase (NOS/ERK/JNK) pathway [111], on the other hand, by reducting oxidative stress, thus preserving endothelial health of the penile corpora cavernosa [112].

4.20 Cordyceps sinensis

Cordyceps sinensis is another medicinal mushroom that has positive effects on sexual function due to its ability to improve cellular energy and blood circulation. In particular, its benefits are due to the stimulation of Adenosine Triphosphate (ATP) production, which increases the energy efficiency of cells and promotes vasodilation to improve penile blood flow, and increased synthesis of NO [113]. In different clinical studies conducted on patients with ED of vascular origin, supplementation with Cordyceps for 8 weeks led to a significant improvement in penile rigidity. Also, in patients with chronic fatigue, Cordyceps increased erectile rigidity, sexual desire and the overall sensation of a firm and sustained erection leading to improvement in sexual performance and confidence [114, 115]. When taken in high doses, Cordyceps sinensis may have a few side effects such as epigastric pain and diarrhea. Therefore, it is important to choose the safe dose and duration of treatment prior to considering it as a possible ergogenic aid in ED patients.

4.21 Capsicum frutescens

Capsicum frutescens is a bioactive compound found in hot chili peppers, known for its stimulating effects on metabolism and blood flow [116]. Specifically, Capsicum frutescens acts as a vasodilator, through a positive effect on the release of NO [116, 117]. Several clinical studies suggest that Capsicum frutescens may be beneficial in the treatment of ED, particularly in cases of mild to moderate ED [116]. Capsicum frutescens supplementation has been demonstrated to lead to a significant improvement in penile hardness, possibly mediated by boosted production of NO in endothelial cells of the corpora cavernosa [117]. Because of its capacity of improving circulation and reducing oxidative stress, Capsicum frutescens might be useful in patients with heart failure-related ED [118].

4.22 Quercetin

Quercetin is a flavonoid found in foods such as apples, onions, red grapes and citrus fruits, known for its potent antioxidant and anti-inflammatory properties [119]. Quercetin has been considered as a potential treatment for ED due to its ability to reduce oxidative stress [119]. Specifically, Quercetin can improve vascular health and promote vasodilation, thereby enhancing blood flow to the penis and improving erectile function [120]. In different studies conducted in patients with mild ED, Quercetin supplementation for 12 weeks showed significant improvements in IIEF scores, with an average increase of 3–4 points [121]. The benefits were primarily attributed to Quercetin-induced reduction in ROS-related alteration of endothelial function [121]. Moreover, Quercetin has been shown to modulate NO production [120].

4.23 Schisandra (schisandra chinensis)

Schisandra is an adaptogenic plant also known for its ability to reduce stress, improve physical resistance and stimulate vital energy, especially used in Chinese medicine for its tonic effects and its ability to balance vital energy, known as “Qi” [122]. Schisandra is mainly used as a tonic, but its therapeutic applications also include the promotion of cardiovascular and sexual health. In addition, this plant seems to have positive effects on blood circulation and production of NO, and is especially appreciated for its antioxidant properties [122, 123, 124]. In different studies conducted in men suffering from stress- or fatigue-related mild ED, Schisandra led to an improvement in erectile rigidity, sexual desire and the overall sensation of a firm and sustained erection leading to improved sexual performance and confidence.

4.24 Astragalus (astragalus membranaceus)

Astragalus is a plant that has been used for thousands of years in traditional Chinese medicine, where it is mainly recognized for its tonic properties and its ability to strengthen the immune system. This plant is used in the treatment of many conditions, but numerous studies underline its beneficial effects on blood circulation and cardiovascular health [125]. Astragalus shows important antioxidant properties, being capable of reducing oxidative stress and protecting the endothelial cells that line the blood vessels, thus preserving the good functioning of the cardiovascular system. Astragalus appears to improve blood flow to the penis by increasing intracellular levels of cyclic adenosine 3′-5′-monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), which are both signaling molecules involved in penile erection. Moreover, this plant has has been shown to have anti-inflammatory properties that can be useful in cases of ED caused by vascular inflammation or damage to the vessels [126]. In a clinical study involving 122 patients with ED, Hongjing I granules, a herbal Chinese medicine containing Astragalus, was significantly superior to a placebo after 8 weeks of treatment, and this was particularly evident in patients with ED related to chronic stress or vascular inflammation [127]. Astragalus might be regarded as a useful supportive treatment for ED, especially for patients with comorbidities such as diabetes or hypertension, in which inflammation and poor blood circulation are predominant factors. Furthermore, its ability to tone the body and improve circulation could contribute to the general improvement of sexual health [128]. Astragalus use is associated to a limited number of side effects such as skin eruption, headache and diarrhea, whose occurrence is however very rare.

4.25 Damiana (turnera diffusa)

Damiana (Turnera diffusa), a plant native to Central and South America, has traditionally been used to increase libido and improve sexual function. This plant is known primarily for its aphrodisiac properties, but its application also extends to the treatment of digestive and respiratory disorders [129]. As for ED, Damiana is often used as a tonic to increase energy and promote sexual well-being by stimulating the central nervous system and hormonal production [130]. Damiana has also been shown to increase the production of dopamine, a neurotransmitter essential in sexual stimulation and desire [129]. Furthermore, Damiana appears to have positive effects on blood circulation by improving blood flow to the penis, which explains its potential use in the treatment of mild to moderate ED [130]. While not a primary treatment for ED, Damiana, due to its aphrodisiac and sexual tonic effects, may be considered a natural option to be used in combination with other treatments, especially in patients with psychogenic or aging-related ED experiencing loss of libido or sexual fatigue [129, 131, 132]. Although research on Damiana for ED is limited, some studies have found significant improvements in IIEF scores. In particular, in one study conducted in men with mild to moderate ED, the use of this herb for six weeks showed an average increase of 2 points in IIEF, with significant benefits regarding erectile strength and sexual satisfaction [132].

4.26 Catuaba (erythroxylum catuaba)

Catuaba (Erythroxylum catuaba) is an aphrodisiac plant native to Brazil that indigenous populations of the Amazon used to increase sexual desire and sexual performance [133]. Although there is currently no impressive clinical evidence in this regard, the plant is used and appreciated for its positive effects on blood circulation and for its stimulating action on the central nervous system (CNS). Catuaba is believed to act as a tonic for the body, also improving resistance and sexual vitality. These properties are due to the alkaloids contained in the plant such as flavonoids and tannins that have an aphrodisiac action [134]. Catuaba is also known for its neuroprotective properties and the ability to increase the production of dopamine, a key neurotransmitter linked to sexual desire and pleasure [134]. Also, it may act as a PDE5i [134]. Although research on Catuaba for ED is limited, some studies indicate that this plant may improve erection quality and stimulate sexual desire in the presence of factors such as stress and fatigue [135]. In fact, in a study conducted in men with mild ED, the supplementation of this compound for eight weeks showed a significant improvement of about 2–3 points in IIEF scores. In addition, treated patients also reported improvements in erection rigidity, duration and sexual satisfaction [136].

4.27 Bacopa monnieri (Brahmi)

Bacopa monnieri, also known as Brahmi, is an adaptogenic herb widely used in Ayurvedic medicine to improve memory, concentration and reduce stress that has recently attracted attention for its potential positive effects on male sexual function. In particular, this herb acts as a tonic for the CNS, helping reduce anxiety and improve the body’s response to stress, which is often responsible of sexual problems [137]. Although research is still limited, there is some evidence that Bacopa monnieri may improve erectile function, particularly in men with psychogenic or stress-induced ED. Furthermore, it has been shown that one of the main mechanisms through which Bacopa monnieri exerts its effects on erectile dysfunction is through the stimulation of NO production [138]. In a study conducted on men with mild ED, administering Bacopa for six weeks led to an average increase of 2 points in IIEF scores, showing improvements in erection and sexual satisfaction [139]. Although the efficacy of Bacopa Monnieri is not yet well established, its positive effects on stress reduction, increased blood circulation and NO production could make it useful in combination with other therapies for ED, especially for those patients suffering from psychogenic ED.

4.28 Suma (pfaffia paniculata)

Suma, also known as “Brazilian ginseng”, is a plant that primarily grows in the Amazon and is traditionally used to boost energy, vitality and improves sexual health [140]. Although scientific research on Suma is still in the preliminary stages, there is evidence to suggest that this plant may have an important action on sexual activation especially for those who suffer from ED due to fatigue or stress. Suma has been shown to increase the production of testosterone, thus counteracting the decrease in libido associated with low hormone levels typically found in a number of patients with ED [141]. Although studies on Suma and ED are limited, some suggest that this herb helps significantly in counteracting poor sexual stamina and low energy levels [142].

4.29 Paeonia lactiflora (Peony)

Paeonia lactiflora or Peony, is a plant used in traditional Chinese medicine to treat various disorders, including those related to sexuality. This plant is known for its anti-inflammatory and antioxidant properties, which can help improve cardiovascular health and blood circulation, therefore it may have a role in the treatment of ED, often linked to circulatory problems [143, 144]. Furthermore, Peony is known for its calming effects, which may help reduce performance anxiety, a common psychological factor that may sometimes play a particularly impactful role in psychogenic ED [144, 145]. It should be noted that although the data at our disposal are still scarce, some small clinical studies have shown that the use of Paeonia supplements leads to improvements in erectile rigidity, sexual desire and the overall sensation of a firm and sustained erection, leading to improved sexual performance and confidence [144, 145]. Furthermore, it has been noted that its anti-inflammatory action may reduce oxidative damage to endothelial cells, improving vascular function and, consequently, supporting erectile function.

4.30 Longjack (eurycoma longifolia)

Longjack or Eurycoma longifolia, is a plant from Southeast Asia that has been used for centuries as a natural aphrodisiac. This plant, also known as Tongkat Ali, is known for its ability to stimulate the production of testosterone, a hormone of vital importance for male sexual health [146]. Longjack has been studied extensively for its positive effects on libido, fertility and sexual function and has also been used to treat hypogonadism, a condition characterized by low testosterone production that is one of the most common causes of ED [147]. The effectiveness of this herb has been analyzed in several clinical studies. In particular, in a study involving 109 men with ED and low testosterone levels, taking Longjack for 12 weeks showed significant improvements in IIEF scores, with an average increase of 3–4 points. In addition, the study participants reported significant improvements from a qualitative point of view in terms of erection hardness, erection duration and sexual satisfaction [148, 149]. The herb seems to act mainly by stimulating testosterone production, but it also improves blood circulation, thereby increasing the supply of oxygen and nutrients to the penile corpora cavernosa. This might be particularly useful for men with vascular-based ED [149]. Longjack has also been shown to have positive effects on fertility, as it appears to improve sperm quality and quantity, making it a very interesting therapeutic option not only for men seeking to improve erectile function, but also for those who have difficulty conceiving [149]. While Longjack is very promising as a natural therapeutic agent for altered sexual function, it is important to note that its effectiveness may vary between individuals and that further research is certainly needed to determine its long-term benefits and the optimal dose for therapy. In summary, Longjack represents a very promising treatment for patients with ED associated with low testosterone levels and may be particularly useful as a complement to hormonal therapies to help improve male sexual health.

4.31 Hypoxis hemerocallidea (African potato)

Hypoxis hemerocallidea, also known as African potato, is a plant from southern Africa traditionally used to treat a variety of disorders, first of all, ED. In fact, the extracts of Hypoxis are rich in phytosterols, saponins and flavonoids, known for their antioxidant and anti-inflammatory properties [150]. Also, the plant acts by increasing testosterone levels and improving blood circulation, two fundamental factors to ensure the sexual health of men [150]. Several clinical studies have shown that Hypoxis extracts lead to an improvement in sexual function, mainly in patients with ED associated with low testosterone levels or vascular problems. In particular, daily intake of Hypoxis extracts resulted in an increase of approximately 2–3 points in IIEF scores, with clear and significant improvements in erection quality and libido [151, 152]. In addition, positive effects have been shown on prostate health, which also is a crucial factor for sexual function [152].

4.32 Sclerocarya birrea (Marula)

Sclerocarya birrea, commonly known as Marula, is a plant native to sub-Saharan Africa, whose fruits and seeds are rich in unsaturated fatty acids, vitamins and antioxidants, which contribute to the improvement of cardiovascular health and, consequently, of erectile function [153]. Traditionally, Marula infusions have been used as a tonic to increase libido and sexual stamina. The plant, in fact, improves blood flow, thus reducing the likelihood of ED related to circulatory problems. Furthermore, Marula is also known for its anti-inflammatory and antioxidant properties, which can help counteract oxidative cell injury and damage to blood vessels [154, 155]. Although evidence-based efficacy of Marula on ED is still limited, because of its beneficial effects on vascular health one may hypothesize that this plant may serve as a therapeutic alternative to treat ED of vascular origin.

4.33 Cissus quadrangularis (veldt grape)

Cissus quadrangularis, commonly known as Veldt grape, is a climbing plant native to Africa, which has traditionally been used to treat a variety of conditions, including ED. Cissus extracts contain antioxidants, flavonoids and phenolic compounds that improve blood circulation and vascular function, especially at the penile cavernous level [156]. The plant is also known for its anti-inflammatory properties and for supporting bone and muscle health, but it is its positive effects on vascular health that make it promising for the treatment of ED [157]. Clinical studies on men with mild ED have shown improvements in IIEF scores, with increases of 2–3 points [158]. Although further research is needed to confirm these results, the plant seems to have a very important potential for the treatment of ED of vascular origin both alone or in combination.

4.34 Kigelia africana (sausage tree)

Kigelia africana, commonly known as the Sausage tree, is a plant native to sub-Saharan Africa that is traditionally used to treat various disorders, including ED [159]. Kigelia extract is rich in flavonoids and phenolic compounds, which have antioxidant and anti-inflammatory properties which are beneficial to sexual health. Also, this plant has been shown to be able to improve blood circulation and stimulate libido [160]. Although data on the effects of Kigelia africana in ED are still limited, some preliminary studies have suggested that Kigelia extracts may have positive effects on erectile quality, with several studies showing that IIEF scores increased by approximately 2–3 points, especially in combination with other aphrodisiac remedies [161]. However, further research is needed to confirm the effectiveness of the plant, and additional clinical studies will certainly be needed to confirm its specific improvements in sexual function.

4.35 Mondia whitei (whitei)

Mondia whitei is a climbing plant from Central and West Africa that is traditionally used as an aphrodisiac, with its extract being used to stimulate testosterone production and help improve blood circulation, two essential factors for proper erectile function [162]. In addition, this plant is also used to treat digestive disorders and to improve physical endurance [163]. A number of preliminary studies have been performed, suggesting that Mondia whitei could also be useful in the treatment of ED, with improvements in erectile rigidity, sexual desire and the overall sensation of a firm and sustained erection, leading to improved sexual performance [164].

4.36 Astragali complanati semen

Semens of Astragali complanati are dried ripe seeds of Flatstem Milkvetch, which is mainly used in traditional Chinese medicine for the treatment of reproductive system diseases such as ED [165]. Among its components complanatoside, astragalin, complanatoside B, and kaempferol have recently been found to be responsible for its anti-ED effect [166]. Astragali complanati semen due to its content of flavonoids also positively affects oxidative stress and lipid metabolism, thus lowering serum lipids. Despite its traditional use for male health, efficacy in ED has never been tested in a systematic manner in clinical trials.

4.37 Detarium senegalense

Detarium senegalense J.F.Gmel. is a medicinal plant native to the west African region and is commonly known as the African star apple or tallow tree, rich in flavonoids, tannins, saponins, alkaloids and phenolic compounds [167]. A recent computational investigation on the therapeutic effects of Detarium senegalense has shown that among its flavonoid components, catechin, epicatechin and gallic acid have the capability of targeting six enzymes which are relevant to erectile function showing a significant binding affinity to PDE5, comparable to that exhibited by sildenafil [168]. Catechin in particular shows superior binding energies, favourable pharmacokinetic profile, and good binding conformation/interaction at the receptor site and might therefore be regarded as a multi-target inhibitor of key enzymes involved in the pathogenesis of ED. Therefore, the flavonoid-rich fraction of Detarium senegalense could lead to improved sexual performance and sustained erection for satisfactory sexual intercourse. Moreover, catechin could serve as a potential lead compound for development of a drug for the management of ED, due to its satisfactory pharmacokinetic profile, good binding affinity and good interaction at the receptor sites of the enzymes. Also, the flavonoid components of Detarium senegalense have shown high gastrointestinal absorption, good bioavailability and drug likeness [168]. Overall, this study supports the potential of Detarium senegalense phytochemicals as promising candidates for developing new, safer and more effective therapies for ED, offering an alternative to current treatments with fewer side effects. However, further research is needed to exactly quantify these compounds in Detarium senegalense and evaluate their efficacy in animal experimental models and, subsequently in clinical trials.

4.38 Fadogia agrestis

Fadogia agrestis, Schweinf. Ex Hiern, locally referred to by the Hausas of Northern Nigeria as gai gai and in English as Black aphrodisiac is a plant belonging to the Rubiaceae family. In ethnomedicine, it has been used to improve athletic performance, to increase sex drive and to treat ED. A recent study conducted in male Wistar rats has shown that aqueous extracts of Fadogia agrestis are capable of restoring the NO/cGMP pathway and ED-associated key enzymes in the penile and testicular tissues, which is attributed to its antioxidant activity [169]. This suggests that aqueous extracts of this medicinal plant should be tested in clinical trials to evaluate whether they may prove useful in the treatment of ED.

4.39 Kaempferia parviflora

Kaempferia parviflora Wall. ex Baker (KP), known in Thailand as Black Ginger or Krachai Dam, belongs to the family of the Zingiberaceae family and is widely distributed in Southeast Asia. It has traditionally been employed to ameliorate physical capacities. Ethnopharmacological evidence indicates that a rhizome of Kaempferia parviflora is able to increase libido and sexual function [170].

5. Clinical usefulness of the most evidence-based nutraceuticals

Leisegang and Finelli [21] and Petre et al. [72] in a systematic review and meta-analysis of recent studies on alternative medicine for ED, have thoroughly evaluated the evidence on the clinical efficacy of the most used phytochemicals and/or nutraceutical formulations in patients with ED (i.e., Panax ginseng, L-arginine, Pycnogenol and Tribulus terrestris).

Panax ginseng efficacy in ED has been investigated in four double-blind RCTs as a single herbal extract having, as an outcome, IIEF improvement. In three of them Panax ginseng was effective at a dose varying from 2000 mg/day for 8 weeks to 3000 mg/day for 8–12 weeks, whereas, in another study, at the dose of 1400 mg/day it showed to be effective at 4 weeks but not at 8 weeks of treatment. The efficacy of Panax ginseng has been confirmed in a metanalysis of 5 studies including 216 ED patients and 153 controls [72]. No significant side effects were reported [21, 72]. Efficacy of Pycnogenol (120 mg/day for 4 months) was tested in two studies as a sole herbal intervention for ED, with both studies reporting improvement in erectile function. Moreover, a nutraceutical formulation of Pycnogenol, L-arginine, L-citrulline and roburins, as a combination therapy, was assessed in four studies all reporting beneficial effects on erectile function and other domains of the IIEF [21]. Also, in an uncontrolled trial, L-arginine caused a non-significant improvement in erectile function over 1 month. Introduction of Pycnogenol together with L-arginine in the same cohort caused a significant improvement of erectile function over the next month; in the third month, doubling the dose of Pycnogenol further improved IIEF in the same cohort of patients, without any adverse events [64]. Petre et al. [72], however, found that L-arginine, in a meta-analysis of four RCTs with 246 patients (intervention group N = 133 patients; control group N = 113 patients), led to a significant improvement in erectile performance as assessed by IIEF. L-arginine has been suggested to be more effective in patients with ED with low NO, where patients with low urinary nitrites and nitrates appear to have greater benefits [21]. This dietary supplement has been reported as a well tolerated natural dietary supplement with good absorption and bioavailability, thus might be considered for long lasting treatment for ED [21]. Tribulus terrestris at a dose ranging from 750 mg to 1560 mg/day for 3 months was investigated as a single herb in two of the studies included in the meta-analysis, both using standardized extractions for saponins, and was reported having a positive effect on the IIEF [21]. However, Santos et al. [46] in a prospective, randomized, double-blind study with Tribulus terrestris extract at a dose of 400 mg/day reported no significant benefit compared to the placebo group. No side effects have been reported in clinical trials in which Tribulus terrestris-based products were administered.

Dosing strategy is relevant and inconsistent outcomes in clinical trials often stem from under-dosing or short treatment duration. For example, L-arginine appears effective only at doses ≥6 g/day sustained over several months [68], whereas earlier trials using ≤3 g/day showed no significant benefit [67]. Similarly, positive results with Tribulus terrestris involved standardized high-saponin extracts at 750 mg/day [45], while negative trials used lower or unstandardized doses [46]. We therefore recommend adhering to dosages validated in literature and maintaining therapy for at least 4–12 weeks to assess efficacy.

6. Discussion

Nutraceuticals offer a viable therapeutic option for ED, thanks to their ability to specifically target many of the pathophysiological mechanisms responsible for ED, coupled with a favorable safety profile (Table 1, Ref. [40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170]). In detail, due to their anti-inflammatory and anti-oxidant activity, they may counteract vascular dysfunction. Moreover, due to stimulatory effects on sex hormones they may be useful in ED related to hormonal imbalance. Finally, because of their ability to stimulate NO production or to inhibit PDE5, they may increase blood supply to the penile corpora cavernosa, thus, exerting a potential beneficial effect in ED related to circulatory problems. In addition, some nutraceuticals with anxiolytic and neuroprotective effects, could help by supporting mental well-being and improving erectile response in patients with ED of psychogenic origin, where anxiety, stress or depression play a significant role.

Table 1.Summary of nutraceuticals’ effect on ED as assessed by improvement in IIEF score and underlying mechanism of action.
Compound/(Plant Family)Active Component and Part UsedMode of ActionAverage IIEF IncreaseReference
Panax Ginseng/(Araliaceae)Ginsenoside Rg1, Rb1, Rg3 extracted from rootIncreases NO production, vasodilation, anti-oxidant and anti-inflammatory effect3–5 points[40, 41, 42, 43]
Tribulus Terrestris/(Zygophillaceae)Protodioscin extracted from fruits (sometimes leaves)Modulates hormone levels by increasing testosterone production and androgen receptor sensitivity2–4 points[44, 45, 46]
Compound/(Plant Family)Active Component and Part UsedMode of ActionAverage IIEF IncreaseReference
Maca (Lepidium meyenii)/(Brassicaceae)Macamidi and macaeni extracted from rootModulates sexual hormones, increases mitochondrial energy production1–2 points[47, 48, 49, 50]
Epimedium (Horny Goat Weed)/(Berberidaceae)Icariin, flavonoids, prenylhydroquinones extracted from leavesPDE5 inhibition, promotes muscle relaxation and increases blood flow2–3 points[51, 52, 53, 54]
Pausinystalia johimbe/(Rubiaceae)Yohimbine extracted from barkAlpha-2 adrenergic receptor antagonist, increases blood flow, stimulates nervous system2–3 points[55, 56, 57, 58]
Saffron (Crocus sativus)/(Iridaceae)Crocin, picrocrocin, safranal extracted from stigmas (red part of the flowers)Antioxidant and neuroprotective, improves penile rigidity, reduces stress3–4 points[59, 60, 61, 62]
L-ArginineL-arginine (isolated amino acid typically from fermentation)Precursor of NO, improves endothelial function and blood flow3–6 points (with Pycnogenol)[63, 64, 65, 66]
Pycnogenol/(Pinaceae)Oligomeric procianidine in bark extract from maritime pine (pinus pinaster)Antioxidant, increases NO production and improves endothelial function3–6points (with L-Arginine)[67, 68, 69]
Ashwagandha/(Solanaceae)Withanolides extracted from root or leavesAdaptogen, reduces cortisol, balances hormones1–3 points[70, 71, 72]
Ginkgo Biloba/(Ginkgoaceae)Ginkgolids, bilobalide extracted from leavesImproves circulation and endothelial function through vasodilation2–4 points[73, 74, 75, 76, 77]
L-CitrullineL-citrulline (isolated aminoacid also found in watermelon)NO precursor with better bioavailability than L-Arginine3–5 points (with Pycnogenol)[78, 79, 80]
Anti-OxidantsPoliphenol and nonpolyphenol flavonoids typically in red wine, fruitsImprove endothelial function, reduces oxidative stress2–4 points[8182, 83, 84, 85, 86]
Vitamin C and EAscorbic acid and tocotrienols in isolated nutrients (fruit, vegetables, oils)Antioxidants, improve vascular health1–2 points (with other nutraceuticals)[87, 88, 89]
Omega-3 Fatty AcidsEPA (eicosapentaenoic acid), DHA (docosahexaenoic acid) in fish or algae oilReduce systemic inflammation and improve vascular signalingNot determined[90, 91, 92]
Zinc and other MicronutrientsElemental zinc (Zn2+) mineral from plant or animal sourcesEssential for testosterone synthesis and hormonal balance1–2 points (especially in case of deficiency)[93, 94, 95]
Probiotics and Gut MicrobiotaBeneficial bacterial strains from food or fermentationImprove gut health, endothelial function and reduce systemic inflammationNot determined[96, 97, 98, 99, 100, 101, 102]
Muira Puama/(Olacaceae)Coumarins extracted from root and barkStimulates central nervous system, improves erectile rigidity and sexual desire3–4 points[103, 104, 105, 106]
Cocoa Polyphenols/(Malvaceae)Epicatechin extracted from seeds (cocoa beans)Increases NO bioavailability, improves blood flow, reduces oxidative stressNot determined[107, 108, 109]
Compound/(Plant Family)Active Component and Part UsedMode of ActionAverage IIEF IncreaseReference
Reishi (Ganoderma lucidum)/(Ganodermataceae)Triterpenes, ganoderic acids extracted from fruiting body (mushroom)Reduces oxidative stress, stimulates NO production, improves vascular healthNot determined[110, 111, 112]
Cordyceps Sinensis/(Cordycipitaceae)Cordycepin, adenosine extracted from fruiting body and myceliumStimulates ATP and NO production, improves blood flow and cellular energyNot determined[113, 114, 115]
Capsicum Frutescens/(Solanaceae)Capsaicin in fruit of chili peppers (Capsicum spp.)Stimulates NO production, improves blood flow, reduces oxidative stressNot determined[116, 117, 118]
Quercetin/(common in Fagaceae, Rosaceae, Fabaceae)Quercetin extracted from onions, apples, berries, green teaAntioxidant and anti-inflammatory, improves endothelial function and vasodilation3–4 points[119, 120, 121]
Schisandra (Schisandra chinensis)/(Schisandraceae)Schisandrin A, B, C extracted from berriesAdaptogen, improves circulation, reduces oxidative stressNot determined[122, 123, 124]
Astragalus (Astragalus membranaceus)/(Fabaceae)Astragalosides extracted from rootAntioxidant and anti-inflammatory, improves blood flow and vascular functionNot determined[125, 126, 127, 128]
Damiana (Turnera diffusa)/(Passifloraceae)Arbutin, damianin extracted from leavesStimulates the central nervous system, improves circulation and sexual desire2 points[129, 130, 131, 132]
Catuaba (Erythroxylum catuaba)/(Erythroxylaceae)Catuabine, tannins extracted from barkStimulates central nervous system, improves circulation and libido2–3 points[133, 134, 135, 136]
Bacopa Monnieri (Brahmi)/(Plantaginaceae)Bacosides extracted from aerial parts (leaves and stems)Reduces stress, improves NO production and vasodilation2 points[137, 138, 139]
Suma (Pfaffia paniculata)/(Amaranthaceae)Ecdysteroids, saponins extracted from rootStimulates testosterone productionNot determined[140, 141, 142]
Paeonia (Peony)/(Paeoniaceae)Paeoniflorin extracted from rootAntioxidant and anti-inflammatory, improves circulation, reduces performance anxietyNot determined[143, 144, 145]
Longjack (Eurycoma longifolia)/(Simaroubaceae)Eurycomanone, quassinoids extracted from rootStimulates testosterone production, improves blood circulation3–4 points[146, 147, 148, 149]
Hypoxis Hemerocallidea (African Potato)/(Hypoxidaceae)Hypoxoside, rooperol extracted from root and rhizomeIncreases testosterone levels and improves circulation2–3 points[150, 151, 152]
Sclerocarya Birrea (Marula)/(Anacardiaceae)Flavonoids and phenolic acids extracted from bark and seedsAntioxidant and anti-inflammatory, improves cardiovascular healthNot determined[153, 154, 155]
Cissus Quadrangularis (Veldt Grape)/(Vitaceae)Quadrangularin A, phytosterols, vitamin C extracted from stemsAntioxidant and anti-inflammatory, improves blood flow2–3 points156, 157, 158]
Kigelia Africana (Sausage Tree)/(Bignoniaceae)Iridoids, kigelinone extracted from fruit and barkImproves circulation and stimulates libido2–3 points[159, 160, 161]
Mondia Whitei/(Apocynaceae)Saponins, alkaloids, coumarins extracted from rootStimulates testosterone production, improves circulationNot determined[162, 163, 164]
Astragali Complanati (Fabaceae)Astragalosides saponins, flavonoids, extracted from rootImproves blood circulation, reduces oxidative stress and influences neurotransmissionNot determined[165, 166]
Compound/(Plant Family)Active Component and Part UsedMode of ActionAverage IIEF IncreaseReference
Detarium senegalense/(Fabaceae)Flavonoids, tannins, triterpenes extracted from bark and seedsImproves NO production and inhibits PDE5Not determined[167, 168]
Fadogia agrestis/(Rubiaceae)Steroidal saponins extracted from stems and rootAntioxidant, restores the NO/cGMP pathway in the penile tissueNot determined[169]
Kaempferia parviflora/(Zingiberaceae)5,7dimethoxyflavone, kaempferol, extracted from rhizomeIncreases libido and sexual functionNot determined[170]
IIEF: International Index of Erectile Function; PDE5: phosphodiesterase type 5; NO: nitric oxide; cGMP: cyclic guanosine monophosphate; ATP: adenosine triphosphate.

An effort should be made in identifying which ED patients are the most suitable for this therapeutical approach. We hypothesize that patients with mild to moderate ED might be among the ideal candidates for the use of nutraceuticals. We however emphasize that nutraceuticals should always be considered as adjuncts to, rather than replacements for, established medical or behavioral interventions, especially lifestyle improvements. Interventions such as weight reduction, physical activity, dietary improvements, and smoking cessation can significantly enhance erectile function, and nutraceuticals may complement these measures. Another group that could benefit from this therapeutical approach are patients who prefer non-pharmacologic options or those who do not respond adequately to PDE5i or who have contraindications to their use, such as those who are on nitrate therapy or have severe cardiovascular disease. Finally, patients with cardiovascular risk factors or metabolic syndrome may also benefit from nutraceuticals, particularly those with vasodilator and antioxidant properties, which may help improve vascular health and, consequently, erectile function.

Further research is needed to standardize dosages, and supplement formulations, to identify the most effective combinations, to assess long-term safety for agents like Cordyceps sinensis, and possible interactions with other nutraceuticals or drugs. Also, studies aimed at dissecting out, at the molecular level, the mechanisms by which nutraceuticals exert their beneficial effects in ED are warranted. Also computational analysis of nutraceuticals may lead to the identification of their most biologically active components, which may serve as a template for developing new, safer and more effective therapies for erectile dysfunction, thereby offering an alternative to current treatments with fewer side effects. Moreover, mounting evidence suggests that alteration of gut microbiota may play a pathogenic role in ED due to the interconnection between microbiome and systemic inflammation, metabolism and vascular health. Identifying the gut microbiota profile which plays a role in the normal sexual functioning or the one which is linked to ED would, therefore, be crucial in planning interventional studies. In this context, Zhang et al. [171] in a two-sample Mendelian randomization study evaluated the causal link between intestinal microbiota and ED by analyzing genetic variants of gut microbiota obtained from MiBioGen consortium containing 18,340 individuals. They found that genetically proxied Lachnospiraceae, Lachnospiraceae NC2004 group, Oscillibacter, Senegalimassilia and Tyzzerella-3 increased the risk of ED, whereas Ruminococcaceae UCG013 were protective against ED [171]. Similar results were obtained by Zhu et al. [172] who confirmed that the 6 bacterial taxa above mentioned possibly have a causal relationship with ED. These studies therefore seem to have been able to identify important bacterial taxa which may serve as candidates for microbiome intervention in future ED clinical trials. Therefore, a promising avenue to pursue is the modulation of gut microbiota in patients with ED through the use of probiotics, prebiotics, symbiotics, dietary interventions, or FMT in order to restore microbial balance and improve erectile function. However, to date, only a small number of observational and pilot studies have explored gut microbiota-targeted strategies in ED, particularly in patients with comorbid metabolic syndrome or obesity. Randomized controlled trials with pre/pro/symbiotic formulations or FMT are necessary in order to clarify whether targeted manipulation of gut microbiota might be an appropriate therapeutic strategy, alone or in association with conventional therapies, in specific types of ED or in ED patients with a peculiar gut microbioma profile.

Because different nutraceuticals may target different aspects of ED, one may envision the use of a given nutraceutical, alone or in combination with conventional therapies and/or life-style modifications, in specific types of ED. In hormone-related ED, nutraceuticals like Tribulus terrestris and Eurycoma longifolia (Tongkat Ali) have demonstrated testosterone-boosting effects in small clinical trials [45, 173]. These agents may support libido and arousal in hypogonadal men, but are not substitutes for testosterone replacement in clinically deficient patients. In psychogenic, anxiety-related ED, agents acting on central arousal pathways, such as Yohimbine, Ashwagandha and Muira puama, may serve as appropriate therapeutic agent [57, 70, 105]. Their use could be particularly relevant when pharmacological therapy has failed in the absence of organic causes. In the case of vasculogenic ED, men with endothelial dysfunction, obesity, type 2 DM or cardiovascular risk factors may benefit from nutraceuticals enhancing NO bioavailability or reducing oxidative stress. In this respect, L-arginine, L-citrulline, Panax ginseng and Pycnogenolhave all shown promise in this therapeutic context [41, 63, 64].

Finally, one must keep in mind that nutraceuticals consist of bioactive compounds which, even though of natural origin, are not necessarily safe, thus, exerting a biological activity which may lead to adverse events. Also, they may interact with other conventional therapeutical agents or with other food components. Nutraceuticals used for ED are generally considered safe, with the majority of clinical trials reporting only mild and transient adverse effects, such as headache or gastrointestinal discomfort [45]. Nonetheless, we acknowledge that rare but clinically relevant adverse events have been documented. For example, Yohimbine may cause hypertension, tachycardia, anxiety, and increased frequency of urination which are consistent with its sympathomimetic action, particularly in sensitive individuals [57]. Also, mild gastrointestinal symptoms have been reported by patients treated with Maca [49]. Finally, Astragalus use may cause a limited number of side effects such as skin eruption, headache and diarrhoea. Moreover, although herb-drug interactions remain relatively uncommon, they are not negligible. Ginkgo biloba, for instance, has been associated with increased bleeding risk when combined with anticoagulants such as warfarin, with some studies reporting a bleeding hazard ratio of 1.3–1.5 [174]. Also, Epimedium sagittatum extracts, and in particular its component icariin, in an experimental study in rats have been demonstrated to alter the pharmacokinetics of sildenafil by decreasing its bioavailability. Therefore, this suggests that co-administration of Epimedium sagittatum extract and sildenafil in clinical practice should be avoided due to potential herb-drug interaction that may impact on the efficacy of sildenafil [175]. Yohimbine may negatively interact with anxyolitic agents due to its stimulating activity of the central 5-hydroxytryptaminergic system, and with anti-hypertensive drugs due to its inhibition of pre-synaptic alpha-2-adrenergic receptors. However, due to its sympathomimetic effects, it has been demonstrated to be able to counteract clonidine-induced toxic states such as depression of the CNS and hypotension [176]. Finally, a theoretical risk of hypotension should be considered when L-arginine is used alongside PDE5i or nitrates. Infact, L-arginine, PDE5i and nitrates increase NO signalling via different mechanisms and therefore may exert a synergistic effect on blood pressure, causing hypotension. Therefore, although severe interactions are rare, clinicians should remain vigilant, especially in patients on multiple therapies.

An additional issue that should be taken into account when using nutraceuticals in general and in the context of ED in particular is the lack of regulatory oversight and standardization which represents a fundamental weakness in their clinical use. The standardization of herbal preparations is crucial for ensuring the reliability and efficacy of medications. Therefore, determining the concentration of their active ingredients and conforming to physical, chemical and physiochemical standards, as well as in vitro and in vivo parameters is of great relevance in order to ensure the efficacy of each nutraceutical product. Unlike pharmaceuticals, dietary supplements are not subjected to pre-market approval by regulatory agencies such as the Food and Drug Administration (FDA), as established by the Dietary Supplement Health and Education Act. Oversight typically occurs only after adverse events are reported [177]. This regulatory gap together with a well established variability in the standardization of plant extracts [178] allows for substantial variability between and even within products. A “ginseng” capsule from one manufacturer may contain different concentrations or purity levels than another, and even batches of the same product may vary in active compound content due to inconsistent sourcing and production processes [179]. This may lead to inconsistency in clinical results, making it difficult to understand the real efficacy or to define the exact dosing of a given herbal product. Also, herbal-herbal or herbal-drug interactions may be difficult to assess if the composition of a product is not well standardized.

Moreover, the global market is invaded by counterfeit and adulterated nutraceuticals claimed to be of natural origin sold with a therapeutic claim. The variability in definition of these products across countries together with differences in the registration procedures may facilitate their manipulation, leading to the diffusion of adulterated and counterfeit products without appropriate control. In fact, many of the nutraceuticals advertised for ED have been found to be adulterated with active pharmaceutical ingredients (i.e., PDE5i) and mislabeled as being natural, thus posing a major health hazard for consumers [23]. Additionally, issues such as contamination with heavy metals and pesticides further highlight the inconsistency and safety concerns linked to poorly regulated products [180]. Adulteration of herbal products may have a severe impact on consumers’ well being, with a possibility of serious adverse effects such as acute liver injury, kidney failure, pulmonary embolism, stroke or even death.

A limitation of this review is that we did not systematically evaluate quality or bias of included studies, even though this is strictly required for systematic reviews and/or meta-analyses and not for a narrative review [181]. However, this review represents a focused summary of the current knowledge and understanding on the topic of nutraceutical use in ED treatment, and provides implications for future research.

7. Conclusions

Nutraceuticals present a valuable therapeutic resource for different profiles of patients with ED, being able to target a number of pathophysiological mechanisms, and with a generally favorable safety profile. However, an individualized approach is essential to optimize their potential therapeutical benefits. Integrating nutraceuticals with conventional existing therapies, including lifestyle interventions, such as healthy diet and exercise, and pharmacological therapy, could significantly improve clinical outcomes and quality of life of patients suffering from this clinical problem which carries such a high negative impact on their relationship life.

Availability of data and materials

There are no datasets included in the study to share.

Author contributions

LR and MM—designed the study and wrote the manuscript. CI, CS, FC, MDS—conceptually reviewed the manuscript. LN, LS, CM, DA, BB, UA and AT—provided help in the literature search. FF, PPP and AC—helped writing the manuscript and collecting data. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Acknowledgment

Not applicable.

Funding

This research received no external funding.

Conflict of interest

The authors declare no conflict of interest. Lorenzo Romano is serving as one of the Editorial Board members of this journal. We declare that Lorenzo Romano had no involvement in the peer review of this article and has no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to BB.

References

Kessler A, Sollie S, Challacombe B, Briggs K, Van Hemelrijck M. The global prevalence of erectile dysfunction: a review. BJU International. 2019; 124: 587–599.

[Google Scholar]

Osondu CU, Vo B, Oni ET, Blaha MJ, Veledar E, Feldman T, et al. The relationship of erectile dysfunction and subclinical cardiovascular disease: a systematic review and meta-analysis. Vascular Medicine. 2018; 23: 9–20.

[Google Scholar]

Romano L, Zagari RM, Arcaniolo D, Crocetto F, Spirito L, Sciorio C, et al. Sexual dysfunction in patients with gastroenterological disorders: do gastroenterologists care enough? A national survey from the Italian Society of Gastroenterology. Digestive and Liver Diseases. 2022; 543: 1494–1501.

[Google Scholar]

Romano L, Pellegrino R, Sciorio C, Barone B, Gravina AG, Santonastaso A, et al. Erectile and sexual dysfunction in male and female patients with celiac disease: a cross‐sectional observational study. Andrology. 2022; 10: 910–918.

[Google Scholar]

Romano L, Fonticelli M, Morisco F, Priadko K, Rocco A, Nardone G, et al. Sexual dysfunctions in well-compensated chronic liver diseases: role of etiology, Mediterranean diet and quality of life in an observational, cross-sectional study. Sexual Medicine. 2025; 13: 1–11.

[Google Scholar]

Cirillo L, Fusco GM, Di Bello F, Morgera V, Cacace G, Di Mauro E, et al. Sexual dysfunction: time for a multidisciplinary approach? Archivio Italiano di Urologia e Andrologia. 2023; 95: 11236.

[Google Scholar]

Maiorino MI, Bellastella G, Esposito K. Diabetes and sexual dysfunction: current perspectives. Diabetes, Metabolic Syndrome and Obesity. 2014; 14: 95–105.

[Google Scholar]

Aversa A, Bruzziches R, Pili M, Spera G. Phosphodiesterase 5 inhibitors in the treatment of erectile dysfunction. Current Pharmaceutical Design. 2006; 12: 3467–3484.

[Google Scholar]

Giovannoni MP, Vergelli C, Graziano A, Dal Piaz V. PDE5 inhibitors and their applications. Current Medicinal Chemistry. 2010; 17: 2564–2587.

[Google Scholar]

Park NC, Kim TN, Park HJ. Treatment strategy for non-responders to PDE5 inhibitors. World Journal of Men’s Health. 2013; 31: 31–35.

[Google Scholar]

Ganu GP, Kolsure PM, Kolhe SS, Dev A, Shintre SS, Dhavale SG, et al. A randomized, multicenter, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of a polyherbal formulation in men with erectile dysfunction. Cureus. 2025; 17: e79613.

[Google Scholar]

Tamler R, Mechanick JJ. Dietary supplements and nutraceuticals in the management of andrologic disorders. Endocrinology and Metabolism Clinics of North America. 2007; 36: 533–552.

[Google Scholar]

Kalra EK. Nutraceutical-definition and introduction. AAPS PharmSciTech. 2003; 5: E25.

[Google Scholar]

Brunetti P, Lo Faro AF, Tini A, Busardò FP, Carlier J. Pharmacology of herbal sexual enhancers: a review of psychiatric and neurological adverse effects. Pharmaceuticals. 2020; 13: 309.

[Google Scholar]

Yafi FA, Jenkins L, Albersen M, Corona G, Isidori AM, Goldfarb S, et al. Erectile dysfunction. Nature Reviews Disease Primers. 2016; 2: 16003.

[Google Scholar]

Lotti F, Maggi M. Sexual dysfunction and male infertility. Nature Reviews Urology. 2018; 15: 287–307.

[Google Scholar]

Andersson K. Erectile physiological and pathophysiological pathways involved in erectile dysfunction. Journal of Urology. 2003; 170: S6–S13; discussion S13–S14.

[Google Scholar]

Corona G, Maggi M. The role of testosterone in erectile dysfunction. Nature Reviews Urology. 2010; 7: 46–56.

[Google Scholar]

Burnett AL. The role of nitric oxide in erectile dysfunction: implications for medical therapy. Journal of Clinical Hypertension. 2006; 8: 53–62.

[Google Scholar]

Aversa A, Bruzziches R, Francomano D, Natali M, Gareri P, Spera G. Endothelial dysfunction and erectile dysfunction in the aging man. International Journal of Urology. 2010; 17: 38–47.

[Google Scholar]

Leisegang K, Finelli R. Alternative medicine and herbal remedies in the treatment of erectile dysfunction: a systematic review. Arab Journal of Urology. 2021; 19: 323–339.

[Google Scholar]

Calogero AE, Aversa A, La Vignera S, Corona G, Ferlin A. The use of nutraceuticals in male sexual and reproductive disturbances: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS). Journal of Endocrinological Investigation. 2017; 40: 1389–1397.

[Google Scholar]

ElAmrawy F, ElAgouri G, Elnoweam O, Aboelazayem S, Farouk E, Nounou MI. Adulterated and counterfeit male enhancement nutraceuticals and dietary supplements pose a real threat to the management of erectile dysfunction: a global perspective. Journal of Dietary Supplements. 2016; 13: 660–693.

[Google Scholar]

Su L, Yang Z, Qu H, Luo C, Yuan G, Wu J, et al. Effect of antioxidants supplementation on erectile dysfunction: a systematic review and meta-analysis of randomized controlled trials. Sexual Medicine Reviews. 2022; 10: 754–763.

[Google Scholar]

Kaltsas A, Zikopoulos A, Dimitriadis F, Sheshi D, Politis M, Moustakli E, et al. Oxidative stress and erectile dysfunction: pathophysiology, impacts, and potential treatments. Current Issues in Molecular Biology. 2024; 46: 8807–8834.

[Google Scholar]

Kulshrestha R, Singla N, Afzal O, Goyal A, Saini M, Altamimi ASA, et al. Role of nutraceuticals in treating erectile dysfunction via inhibition of Phosphodiesterase-5 enzyme: a mini review. Current Pharmaceutical Biotechnology. 2024; 25: 1905–1914.

[Google Scholar]

Gao Y, Liu C, Lu X, Lu K, Zhang L, Mao W, et al. Lycopene intake and the risk of erectile dysfunction in us adults: NHANES 2001–2004. Andrology. 2024; 12: 45–55.

[Google Scholar]

Olabiyi AA, Ajayi K. Diet, herbs and erectile function: a good friendship! Andrologia. 2022; 54: e14424.

[Google Scholar]

Abdelwahab SI, Taha MME. A systematic literature review of natural products for male sexual dysfunction. Urologia Journal. 2024; 91: 647–658.

[Google Scholar]

Aversa A, Isidori AM, Greco EA, Giannetta E, Gianfrilli D, Spera E, et al. Hormonal supplementation and erectile dysfunction. European Urology. 2004; 45: 535–538.

[Google Scholar]

Boloña ER, Uraga MV, Haddad RM, Tracz MJ, Sideras K, Kennedy CC, et al. Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clinic Proceedings. 2007; 82: 20–28.

[Google Scholar]

Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nature Reviews Endocrinology. 2009; 5: 673–681.

[Google Scholar]

Jones TH, Saad F. The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process. Atherosclerosis. 2009; 207: 318–327.

[Google Scholar]

Kloner RA, Carson C, Dobs A, Kopecky S, Mohler ER. Testosterone and cardiovascular disease. Journal of the American College of Cardiology. 2016; 67: 545–557.

[Google Scholar]

Allen MS, Walter EE. Erectile dysfunction: an umbrella review of meta-analyses of risk-factors, treatment, and prevalence outcomes. Journal of Sexual Medicine. 2019; 16: 531–541.

[Google Scholar]

Allen MS, Wood AM, Sheffield D. The psychology of erectile dysfunction. Current Directions in Psychological Science. 2023; 32: 487–493.

[Google Scholar]

Mamidi P, Thakar A. Efficacy of Ashwagandha (Withania somnifera Dunal. Linn.) in the management of psychogenic erectile dysfunction. AYU. 2011; 32: 322–328.

[Google Scholar]

AlAli M, Alqubaisy M, Aljaafari MN, AlAli AO, Baqais L, Molouki A, et al. Nutraceuticals: transformation of conventional foods into health promoters/disease preventers and safety considerations. Molecules. 2021; 26: 2540.

[Google Scholar]

Roy RK, Thakur M, Dixit VK. Development and evaluation of polyherbal formulation for hair growth–promoting activity. Journal of Cosmetic Dermatology. 2007; 6: 108–112.

[Google Scholar]

Kim T, Jeon SH, Hahn E, Paek K, Park JK, Youn NY, et al. Effects of tissue-cultured mountain ginseng (Panax ginseng CA Meyer) extract on male patients with erectile dysfunction. Asian Journal of Andrology. 2009; 11: 356–361.

[Google Scholar]

Leung KW, Wong AS. Ginseng and male reproductive function. Spermatogenesis. 2013; 3: e26391.

[Google Scholar]

Choi YD, Park CW, Jang J, Kim SH, Jeon HY, Kim WG, et al. Effects of Korean ginseng berry extract on sexual function in men with erectile dysfunction: a multicenter, placebo-controlled, double-blind clinical study. International Journal of Impotence Research. 2013; 25: 45–50.

[Google Scholar]

Lee HW, Lee MS, Kim T, Alraek T, Zaslawski C, Kim JW, et al. Ginseng for erectile dysfunction: a Cochrane systematic review. World Journal of Men’s Health. 2022; 40: 264–269.

[Google Scholar]

Stefanescu R, Tero-Vescan A, Negroiu A, Aurică E, Vari CE. A comprehensive review of phytochemical, pharmacological, and toxicological properties of Tribulus terrestris L. Biomolecules. 2020; 10: 752.

[Google Scholar]

Kamenov Z, Fileva S, Kalinov K, Jannini EA. Evaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction—a prospective, randomized, double-blind, placebo-controlled clinical trial. Maturitas. 2017; 99: 20–26.

[Google Scholar]

Santos CA, Reis LO, Destro-Saade R, Luiza-Reis A, Fregonesi A. Tribulus terrestris versus placebo in the treatment of erectile dysfunction: a prospective, randomized, double-blind study. Actas UrolóGicas EspañOlas. 2014; 38: 244–248.

[Google Scholar]

Lee HW, Lee MS, Kil KJ. Maca (L. meyenii) for erectile dysfunction: a systematic review and meta-analysis. Journal of Men’s Health. 2023; 19: 1–6.

[Google Scholar]

Shin B, Lee MS, Yang EJ, Lim H, Ernst E. Maca (L. meyenii) for improving sexual function: a systematic review. BMC Complementary and Alternative Medicine. 2010; 10: 44.

[Google Scholar]

Zenico T, Cicero AF, Valmorri L, Mercuriali M, Bercovich E. Subjective effects of Lepidium meyenii (Maca) extract on well‐being and sexual performances in patients with mild erectile dysfunction: a randomised, double‐blind clinical trial. Andrologia. 2009; 41: 95–99.

[Google Scholar]

Kamohara S, Kageyama M, Sunayama S, Denpo K. Safety and efficacy of a dietary supplement containing functional food ingredients for erectile dysfunction. Personalized Medicine Universe. 2014; 3: 38–41.

[Google Scholar]

Ho CCK, Tan HM. Rise of herbal and traditional medicine in erectile dysfunction management. Current Urology Reports. 2011; 12: 470–478.

[Google Scholar]

Li J, He Y, Zheng X, Li S, Wu Y, Shi W, et al. Flavonoids and prenylhydroquinones from the prepared folium of Epimedium sagittatum Maxim. and their inhibition against phosphodiesterase5a. Fitoterapia. 2023; 168: 105465.

[Google Scholar]

Zhuang W, Sun N, Gu C, Liu S, Zheng Y, Wang H, et al. A literature review on Epimedium, a medicinal plant with promising slow aging properties. Heliyon. 2023; 9: e21226.

[Google Scholar]

Mahboubi M. Epimedium brevicornum Maxim and its efficacy in the treatment of sexual dysfunction. Natural Products Journal. 2021; 11: 438–447.

[Google Scholar]

Morales A. Yohimbine in erectile dysfunction: the facts. International Journal of Impotence Research. 2000; 12: S70–S74.

[Google Scholar]

Ernst E, Pittler MH. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. Journal of Urology. 1998; 159: 433–436.

[Google Scholar]

Wibowo DNSA, Soebadi DM, Soebadi MA. Yohimbine as a treatment for erectile dysfunction: a systematic review and meta-analysis. Turkish Journal of Urology. 2021; 47: 482–488.

[Google Scholar]

Mann K, Klingler T, Noe S, Röschke J, Müller S, Benkert O. Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction. Archives of Sexual Behavior. 1996; 25: 1–16.

[Google Scholar]

Goyal A, Raza FA, Sulaiman SA, Shahzad A, Aaqil SI, Iqbal M, et al. Saffron extract as an emerging novel therapeutic option in reproduction and sexual health: recent advances and future perspectives. Annals of Medicine and Surgery. 2024; 86: 2856–2865.

[Google Scholar]

Maleki-Saghooni N, Mirzaeii K, Hosseinzadeh H, Sadeghi R, Irani M. A systematic review and meta-analysis of clinical trials on saffron (Crocus sativus) effectiveness and safety on erectile dysfunction and semen parameters. Avicenna Journal of Phytomedicine. 2018; 8: 198–209.

[Google Scholar]

Safarinejad MR, Shafiei N, Safarinejad S. An open label, randomized, fixed-dose, crossover study comparing efficacy and safety of sildenafil citrate and saffron (Crocus sativus Linn.) for treating erectile dysfunction in men naïve to treatment. International Journal of Impotence Research. 2010; 22: 240–250.

[Google Scholar]

Ranjbar H, Ashrafizaveh A. Effects of saffron (Crocus sativus) on sexual dysfunction among men and women: a systematic review and meta-analysis. Avicenna Journal of Phytomedicine. 2019; 9: 419–427.

[Google Scholar]

Koolwal A, Manohar JS, Rao TSS, Koolwal GD. L-arginine and erectile dysfunction. Journal of Psychosexual Health. 2019; 1: 37–43.

[Google Scholar]

Stanislavov R, Nikolova V. Treatment of erectile dysfunction with pycnogenol and L-arginine. Journal of Sex & Marital Therapy. 2003; 29: 207–213.

[Google Scholar]

Tian Y, Zhou Q, Li W, Liu M, Li Q, Chen Q. Efficacy of L-arginine and Pycnogenol® in the treatment of male erectile dysfunction: a systematic review and meta-analysis. Frontiers in Endocrinology. 2023; 14: 1211720.

[Google Scholar]

Klotz T, Mathers MJ, Braun M, Bloch W, Engelmann U. Effectiveness of oral L-arginine in first-line treatment of erectile dysfunction in a controlled crossover study. Urologia Internationalis. 2000; 63: 220–223.

[Google Scholar]

Chen J, Wollman Y, Chernichovsky T, Iaina A, Sofer M, Matzkin H. Effect of oral administration of high‐dose nitric oxide donor L‐arginine in men with organic erectile dysfunction: results of a double‐blind, randomized, placebo‐controlled study. BJU International. 1999; 83: 269–273.

[Google Scholar]

Menafra D, de Angelis C, Garifalos F, Mazzella M, Galdiero G, Piscopo M, et al. Long-term high-dose L-arginine supplementation in patients with vasculogenic erectile dysfunction: a multicentre, double-blind, randomized, placebo-controlled clinical trial. Journal of Endocrinological Investigation. 2022; 45: 941–961.

[Google Scholar]

D̆uračková Z, Trebatický B, Novotný V, Žitňanová I, Breza J. Lipid metabolism and erectile function improvement by pycnogenol®, extract from the bark of pinus pinaster in patients suffering from erectile dysfunction—a pilot study. Nutrition Research. 2003; 23: 1189–1198.

[Google Scholar]

Welch J, Bashir H, Daniels S. The effectiveness of Whitania somnifera supplementation on male sexual health: A systematic review of randomized clinical trials. Journal of Medicinal Plants Studies. 2023; 11: 34–38.

[Google Scholar]

Chauhan S, Srivastava MK, Pathak AK. Effect of standardized root extract of ashwagandha (Withania somnifera) on well-being and sexual performance in adult males: a randomized controlled trial. Health Science Reports. 2022; 5: e741.

[Google Scholar]

Petre GC, Francini-Pesenti F, Vitagliano A, Grande G, Ferlin A, Garolla A. Dietary supplements for erectile dysfunction: analysis of marketed products, systematic review, meta-analysis and rational use. Nutrients. 2023; 15: 3677.

[Google Scholar]

Alrumaihi F, Raut R, Yahia E, Kumar V, Anwar S. A review on risk factors, diagnostic innovations, and plant based therapies for the management of erectile dysfunction. Uro. 2024; 4: 60–88.

[Google Scholar]

Sohn M, Sikora R. Ginkgo biloba extract in the therapy of erectile dysfunction. Journal of Sex Education and Therapy. 1991; 17: 53–61.

[Google Scholar]

McKay D. Nutrients and botanicals for erectile dysfunction: examining the evidence. Alternative Medicine Review. 2004; 9: 4–16.

[Google Scholar]

Cohen AJ, Bartlik B. Ginkgo biloba for antidepressant-induced sexual dysfunction. Journal of Sex & Marital Therapy. 1998; 24: 139–143.

[Google Scholar]

Derosa G, D’Angelo A, Petri PS, Maffioli P. Evaluation of the effect on sexual performance of a nutraceutical combination containing Alpha Lipoic Acid, Vitis vinifera L. and Ginkgo biloba, compared to placebo, Avanafil or a combination of nutraceutical plus Avanafil in males with Type 2 Diabetes Mellitus with erectile dysfunction. Frontiers in Endocrinology. 2022; 13: 847240.

[Google Scholar]

Cormio L, De Siati M, Lorusso F, Selvaggio O, Mirabella L, Sanguedolce F, et al. Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. Urology. 2011; 77: 119–122.

[Google Scholar]

Ferrini MG, Hlaing SM, Chan A, Artaza JN. Treatment with a combination of ginger, L-citrulline, muira puama and Paullinia cupana can reverse the progression of corporal smooth muscle loss, fibrosis and veno-occlusive dysfunction in the aging rat. Andrology. 2015; 4: 132.

[Google Scholar]

Shirai M, Hiramatsu I, Aoki Y, Shimoyama H, Mizuno T, Nozaki T, et al. Oral L-citrulline and transresveratrol supplementation improves erectile function in men with phosphodiesterase 5 inhibitors: a randomized, double-blind, placebo-controlled crossover pilot study. Sexual Medicine. 2018; 6: 291–296.

[Google Scholar]

Soner BC, Murat N, Demir O, Guven H, Esen A, Gidener S. Evaluation of vascular smooth muscle and corpus cavernosum on hypercholesterolemia. Is resveratrol promising on erectile dysfunction? International Journal of Impotence Research. 2010; 22: 227–233.

[Google Scholar]

Ramasamy R, Bhattacharyya S, Kohn TP, Miller LE. Antioxidant supplementation for erectile dysfunction: systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials. World Journal of Men’s Health. 2025; 43: 81–91.

[Google Scholar]

Shirai M, Miyoshi Y, Ogasa T, Miyoshi M, Ishikawa K, Hiramatsu I, et al. Oral testofen, L-citrulline, resveratrol and caffeine supplement drink improves sexual function in men with phosphodiesterase 5 inhibitors: randomized, double-blind, placebo-controlled cross-over pilot study. World Journal of Mens Health. 2021; 39: 733–739.

[Google Scholar]

Mishra R, Nikam A, Hiwarkar J, Nandgude T, Bayas J, Polshettiwar S. Flavonoids as potential therapeutics in male reproductive disorders. Future Journal of Pharmaceutical Sciences. 2024; 10: 100.

[Google Scholar]

Eleazu C, Obianuju N, Eleazu K, Kalu W. The role of dietary polyphenols in the management of erectile dysfunction—mechanisms of action. Biomedicine & Pharmacotherapy. 2017; 88: 644–652.

[Google Scholar]

Cassidy A, Franz M, Rimm EB. Dietary flavonoid intake and incidence of erectile dysfunction. American Journal of Clinical Nutrition. 2016; 103: 534–541.

[Google Scholar]

Tadayon Najafabadi B, Jafarinia M, Ghamari K, Shokraee K, Tadayyon F, Akhondzadeh S. Vitamin E and ginseng combined supplement for treatment of male erectile dysfunction: a double-blind, placebo-controlled, randomized, clinical trial. Advances in Integrative Medicine. 2021; 8: 44–49.

[Google Scholar]

Mykoniatis I, Grammatikopoulou MG, Bouras E, Karampasi E, Tsionga A, Kogias A, et al. Sexual dysfunction among young men: overview of dietary components associated with erectile dysfunction. Journal of Sexual Medicine. 2018; 15: 176–182.

[Google Scholar]

Aversa A. Strategies to improve endothelial function and its clinical relevance to erectile dysfunction. European Urology Supplements. 2009; 8: 71–79.

[Google Scholar]

Yang B, Wei C, Zhang Y, Ma D, Bai J, Liu Z, et al. Association between improved erectile function and dietary patterns: a systematic review and meta-analysis. Asian Journal of Andrology. 2025; 27: 239–244.

[Google Scholar]

Kirby M. The circle of lifestyle and erectile dysfunction. Sexual Medicine Reviews. 2015; 3: 169–182.

[Google Scholar]

Meldrum DR, Gambone JC, Morris MA, Ignarro LJ. A multifaceted approach to maximize erectile function and vascular health. Fertility and Sterility. 2010; 94: 2514–2520.

[Google Scholar]

Liu RJ, Li SY, Xu ZP, Yu JJ, Mao WP, Sun C, et al. Dietary metal intake and the prevalence of erectile dysfunction in US men: results from National Health and Nutrition Examination Survey 2001–2004. Frontiers in Nutrition. 2022; 9: 974443.

[Google Scholar]

Rył A, Ciosek Ż, Szylińska A, Jurewicz A, Bohatyrewicz A, Rotter I. Concentrations of Bioelements (Zn, Cu, Fe, Cr, Mg, Mn) in serum and bone tissue of aging men undergoing hip arthroplasty: implications for erectile dysfunction. Biomolecules. 2024; 14: 565.

[Google Scholar]

Kuchakulla M, Narasimman M, Soni Y, Leong JY, Patel P, Ramasamy R. A systematic review and evidence-based analysis of ingredients in popular male testosterone and erectile dysfunction supplements. International Journal of Impotence Research. 2021; 33: 311–317.

[Google Scholar]

Priadko K, Romano L, Olivieri S, Romeo M, Barone B, Sciorio C, et al. Intestinal microbiota, intestinal permeability and the urogenital tract: is there a pathophysiological link? Journal of Physiology and Pharmacology. 2022; 73: 575–585.

[Google Scholar]

Romano L, Pellegrino R, Arcaniolo D, Gravina AG, Miranda A, Priadko K, et al. Lower urinary tract symptoms in patients with inflammatory bowel diseases: a cross-sectional observational study. Digestive and Liver Disease. 2024; 56: 628–634.

[Google Scholar]

Romano L, Napolitano L, Crocetto F, Sciorio C, Sio MD, Miranda A, et al. Prostate and gut: any relationship? a narrative review on the available evidence and putative mechanisms. Prostate. 2024; 84: 513–524.

[Google Scholar]

Romano L, Napolitano L, Crocetto F, Sciorio C, Priadko K, Fonticelli M, et al. The potential therapeutic role of Hericium erinaceus extract in pathologic conditions involving the urogenital-gut axis: insights into the involved mechanisms and mediators. Journal of Physiology and Pharmacology. 2024; 75: 1, 3–9.

[Google Scholar]

Leelani N, Bole R, Khooblall P, Bajic P, Lundy SD. The role of the microbiome in erectile dysfunction. Current Sexual Health Reports. 2023; 15: 132–137.

[Google Scholar]

Kaltsas A, Giannakodimos I, Markou E, Adamos K, Stavropoulos M, Kratiras Z, et al. The role of gut microbiota dysbiosis in erectile dysfunction: from pathophysiology to treatment strategies. Microorganisms. 2025; 13: 250.

[Google Scholar]

Russo GI, Bongiorno D, Bonomo C, Musso N, Stefani S, Sokolakis I, et al. The relationship between the gut microbiota, benign prostatic hyperplasia, and erectile dysfunction. International Journal of Impotence Research. 2023; 35: 350–355.

[Google Scholar]

Balasubramanian A, Thirumavalavan N, Srivatsav A, Yu J, Hotaling JM, Lipshultz LI, et al. An analysis of popular online erectile dysfunction supplements. Journal of Sexual Medicine. 2019; 16: 843–852.

[Google Scholar]

Ferrini MG, Garcia E, Abraham A, Artaza JN, Nguyen S, Rajfer J. Effect of ginger, Paullinia cupana, muira puama and l-citrulline, singly or in combination, on modulation of the inducible nitric oxide- NO-cGMP pathway in rat penile smooth muscle cells. Nitric Oxide. 2018; 76: 81–86.

[Google Scholar]

Bella AJ, Shamloul R. Traditional plant aphrodisiacs and male sexual dysfunction. Phytotherapy Research. 2014; 28: 831–835.

[Google Scholar]

Rowland DL, Tai W. A review of plant-derived and herbal approaches to the treatment of sexual dysfunctions. Journal of Sex & Marital Therapy. 2003; 29: 185–205.

[Google Scholar]

Rimbach G, Melchin M, Moehring J, Wagner AE. Polyphenols from cocoa and vascular health—a critical review. International Journal of Molecular Sciences. 2009; 10: 4290–4309.

[Google Scholar]

Shamloul R. Natural aphrodisiacs. Journal of Sexual Medicine. 2010; 7: 39–49.

[Google Scholar]

Ly C, Yockell-Lelièvre J, Ferraro ZM, Arnason JT, Ferrier J, Gruslin A. The effects of dietary polyphenols on reproductive health and early development. Human Reproduction Update. 2015; 21: 228–248.

[Google Scholar]

Ahmed H, Aslam M. Evaluation of aphrodisiac activity of ethanol extract of Ganoderma lucidum in male Wistar rats. Clinical Phytoscience. 2018; 4: 26.

[Google Scholar]

Yao X, Yuan Y, Jing T, Ye S, Wang S, Xia D. Ganoderma lucidum polysaccharide ameliorated diabetes mellitus-induced erectile dysfunction in rats by regulating fibrosis and the NOS/ERK/JNK pathway. Translational Andrology and Urology. 2022; 11: 982–995.

[Google Scholar]

Feng Y, Shi T, Fu Y, Lv B. Traditional Chinese medicine to prevent and treat diabetic erectile dysfunction. Frontiers in Pharmacology. 2022; 13: 956173.

[Google Scholar]

Dong CH, Yao YJ. In vitro evaluation of antioxidant activities of aqueous extracts from natural and cultured mycelia of Cordyceps sinensis. Lebensmittel-Wissenschaft & Technologie. 2008; 41: 669–677.

[Google Scholar]

Jiraungkoorskul K, Jiraungkoorskul W. Review of naturopathy of medical mushroom, Ophiocordyceps sinensis, in sexual dysfunction. Pharmacognosy Reviews. 2016; 10: 1–5.

[Google Scholar]

Zhu JS, Halpern GM, Jones K. The scientific rediscovery of an ancient Chinese herbal medicine: Cordyceps sinensis: part I. Journal of Alternative and Complementary Medicine. 1998; 4: 289–303.

[Google Scholar]

Kamatenesi-Mugisha M, Oryem-Origa H. Traditional herbal remedies used in the management of sexual impotence and erectile dysfunction in western Uganda. African Health Sciences. 2005; 5: 40–49.

[Google Scholar]

C Guyamin M, L Guda M, Mae U Palec R. Effects of Capsicum frutescens L. (Siling Labuyo) on the Sexual Behavior of Male Rattus norvegicus (Albino Rats). International Journal of Science and Research. 2018; 7: 1454–1458.

[Google Scholar]

Alberti L, Torlasco C, Lauretta L, Loffi M, Maranta F, Salonia A, et al. Erectile dysfunction in heart failure patients: a critical reappraisal. Andrology. 2013; 1: 177–191.

[Google Scholar]

Ranawat P, Pathak CM, Khanduja KL. A new perspective on the quercetin paradox in male reproductive dysfunction. Phytotherapy Research. 2013; 27: 802–810.

[Google Scholar]

Adefegha SA, Oboh G, Fakunle B, Oyeleye SI, Olasehinde TA. Quercetin, rutin, and their combinations modulate penile phosphodiesterase-5′, arginase, acetylcholinesterase, and angiotensin-I-converting enzyme activities: a comparative study. Comparative Clinical Pathology. 2018; 27: 773–780.

[Google Scholar]

Xu D, Zhang Y, Bai J, Yuan H, Wang T, Liu J, et al. Botanical drugs for treating erectile dysfunction: clinical evidence. Frontiers in Pharmacology. 2023; 14: 1232774.

[Google Scholar]

Choo SH, Sung HH, Chae MR, Kang SJ, Han DH, Park JK, et al. Effects of Schisandra chinensis extract on the relaxation of isolated human prostate tissue and smooth muscle cell. Journal of Ethnopharmacology. 2014; 156: 271–276.

[Google Scholar]

Kim HK, Bak YO, Choi BR, Zhao C, Lee HJ, Kim CY, et al. The role of the lignan constituents in the effect of Schisandra chinensis fruit extract on penile erection. Phytotherapy Research. 2011; 25: 1776–1782.

[Google Scholar]

Choi BR, Kim HK, Park JK. Effects of Schisandra chinensis fruit extract and gomisin A on the contractility of penile corpus cavernosum smooth muscle: a potential mechanism through the nitric oxide-cyclic guanosine monophosphate pathway. Nutrition Research and Practice. 2018; 12: 291–297.

[Google Scholar]

Chye PL. Traditional Asian folklore medicines in sexual health. Indian Journal of Urology. 2006; 22: 241–245.

[Google Scholar]

Nasir A, Yabalak E. Exploring natural herbs: their role in treating male infertility, enhancing sexual desire and addressing urological disorders. International Journal of Environmental Research and Public Health. 2024; 3: 1–27.

[Google Scholar]

Xu RN, Guo J, Zhang CH, Zhou Q, Gen Q, Wang F, et al. Efficacy of Hongjing I granule, an herbal medicine, in patients with mild to moderate erectile dysfunction in a randomized controlled trial. Frontiers in Pharmacology. 2024; 15: 1367812.

[Google Scholar]

Opuwari CS. Herbal medicines (Eleutherococcus senticosus, Astragalus membranaceus) used to treat andrological problems: Asia and Indian Subcontinent. Herbal Medicine in Andrology. 2021; 13: 113–121.

[Google Scholar]

Yarnell E. Herbs for erectile dysfunction. Alternative and Complementary Therapies. 2015; 21: 276–283.

[Google Scholar]

Szewczyk K, Zidorn C. Ethnobotany, phytochemistry, and bioactivity of the genus Turnera (Passifloraceae) with a focus on damiana—Turnera diffusa. Journal of Ethnopharmacology. 2014; 152: 424–443.

[Google Scholar]

Estrada-Reyes R, Ortiz-López P, Gutiérrez-Ortíz J, Martínez-Mota L. Turnera diffusa Wild (Turneraceae) recovers sexual behavior in sexually exhausted males. Journal of Ethnopharmacology. 2009; 123: 423–429.

[Google Scholar]

West E, Krychman M. Natural aphrodisiacs—a review of selected sexual enhancers. Sexual Medicine Reviews. 2015; 3: 279–288.

[Google Scholar]

Kletter C, Glasl S, Presser A, Werner I, Reznicek G, Narantuya S, et al. Morphological, chemical and functional analysis of catuaba preparations. Planta Medica. 2004; 70: 993–1000.

[Google Scholar]

Anand Ganapathy A, Hari Priya VM, Kumaran A. Medicinal plants as a potential source of Phosphodiesterase-5 inhibitors: a review. Journal of Ethnopharmacology. 2021; 267: 113536.

[Google Scholar]

Mendes FR. Tonic, fortifier and aphrodisiac: adaptogens in the Brazilian folk medicine. Revista Brasileira de Farmacognosia. 2011; 21: 754–763.

[Google Scholar]

Shah GR, Chaudhari MV, Patankar SB, Pensalwar SV, Sabale VP, Sonawane NA. Evaluation of a multi-herb supplement for erectile dysfunction: a randomized double-blind, placebo-controlled study. BMC Complementary and Alternative Medicine. 2012; 12: 155.

[Google Scholar]

Mondal S, Bhar K, Mondal P, Panigrahi N, Sahoo SK, Swetha P, et al. In quest of the mysterious holistic vedic herb bacopa monnieri (L.) Pennell. Pharmacognosy Research. 2023; 15: 410–454.

[Google Scholar]

Rajender S. Potent natural aphrodisiacs for the management of erectile dysfunction and male sexual debilities. Frontiers in Bioscience. 2012; 4: 167–180.

[Google Scholar]

Deepak V, Ashwini K S, Megha S. A randomised clinical control study to evaluate the efficacy of Shodhita Kuchla Powder (Purified Strychnos Nux-Vomica L.) and Brahmi Extract (Bacopa Monnieri L. Pennell) on Klaibya (Dhwajbhang) w.s.r. to erectile dysfunction. Ayushdhara. 2021; 8: 3511–3523.

[Google Scholar]

Mendes FR, Carlini EA. Brazilian plants as possible adaptogens: an ethnopharmacological survey of books edited in Brazil. Journal of Ethnopharmacology. 2007; 109: 493–500.

[Google Scholar]

Srivatsav A, Balasubramanian A, Pathak UI, Rivera-Mirabal J, Thirumavalavan N, Hotaling JM, et al. Efficacy and safety of common ingredients in aphrodisiacs used for erectile dysfunction: a review. Sexual Medicine Reviews. 2020; 8: 431–442.

[Google Scholar]

da Silva CV, Borges FM, Velozo ES. Phytochemistry of some Brazilian plants with aphrodisiac activity. In Rao A (ed.) Phytochemicals—a global perspective of their role in nutrition and health (pp. 307–326). 1st edn. IntechOpen Publisher: London. 2012.

[Google Scholar]

He DY, Dai SM. Anti-inflammatory and immunomodulatory effects of paeonia lactiflora pall., a traditional Chinese herbal medicine. Frontiers in Pharmacology. 2011; 2: 10.

[Google Scholar]

Xu RN, Ma JX, Zhang X, Liao ZD, Fu YJ, Lv BD. Efficacy of Chinese herbal medicine formula in the treatment of mild to moderate erectile dysfunction: Study protocol for a multi-center, randomized, double-blinded, placebo-controlled clinical trial. International Journal of General Medicine. 2023; 16: 5501–5513.

[Google Scholar]

Guo W, Yao X, Cui R, Yang W, Wang L. Mechanisms of paeoniaceae action as an antidepressant. Frontiers in Pharmacology. 2023; 13: 934199.

[Google Scholar]

Kotirum S, Ismail SB, Chaiyakunapruk N. Efficacy of tongkat ali (Eurycoma longifolia) on erectile function improvement: systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine. 2015; 23: 693–698.

[Google Scholar]

Bin Mohd Tambi MI, Imran MK. Eurycoma longifolia Jack in managing idiopathic male infertility. Asian Journal of Andrology. 2010; 12: 376–380.

[Google Scholar]

Thu HE, Mohamed IN, Hussain Z, Jayusman PA, Shuid AN. Eurycoma Longifolia as a potential adaptogen of male sexual health: a systematic review on clinical studies. Chinese Journal of Natural Medicines. 2017; 15: 71–80.

[Google Scholar]

Leisegang K, Finelli R, Sikka SC, Panner Selvam MK. Eurycoma longifolia (Jack) improves serum total testosterone in men: a systematic review and meta-analysis of clinical trials. Medicina. 2022; 58: 1047.

[Google Scholar]

Semenya SS, Potgieter MJ. Ethnobotanical survey of medicinal plants used by Bapedi traditional healers to treat erectile dysfunction in the Limpopo Province, South Africa. Journal of Medicinal Plants Research. 2013; 7: 349–357.

[Google Scholar]

Fatma H, Siddique HR. Herbal medicine to cure male reproductive dysfunction. Herbal Medicines. 2022; 18: 409–435.

[Google Scholar]

Matyanga CMJ, Morse GD, Gundidza M, Nhachi CFB. African potato (Hypoxis hemerocallidea): a systematic review of its chemistry, pharmacology and ethno medicinal properties. BMC Complementary Medicine and Therapies. 2020; 20: 182.

[Google Scholar]

Abdalbasit AM, Siddig I. Sclerocarya birrea (Marula), an African tree of nutritional and medicinal uses: a review. Food Research International. 2012; 28: 375–388.

[Google Scholar]

Mashau ME, Kgata TE, Makhado MV, Mikasi MS, Ramashia SE. Nutritional composition, polyphenolic compounds and biological activities of marula fruit (Scerocarya birrea) with its potential food applications: a review. International Journal of Food Properties. 2022; 25: 1549–1575.

[Google Scholar]

Sewani-Rusike CR, Iputo JE, Ndebia EJ, Gondwe M, Kamadyaapa DR. A comparative study on the aphrodisiac activity of food plants Mondia whitei, Chenopodium album, Cucurbita pepo and Sclerocarya birrea extracts in male wistar rats. African Journal of Traditional, Complementary and Alternative Medicines. 2015; 12: 22–26.

[Google Scholar]

Akinjiyan MO, Elekofehinti OO, Oluwatuyi AO, Nwanna EE, Lawal AO. Investigation of Cissus populnea as a potential therapeutic agent for erectile dysfunction. Cell Biochemistry and Biophysics. 2025; 83: 555–572.

[Google Scholar]

Sawangjit R, Puttarak P, Saokaew S, Chaiyakunapruk N. Efficacy and safety of Cissus quadrangularis L. in clinical use: a systematic review and meta-analysis of randomized controlled trials. Phytotherapy Research. 2017; 31: 555–567.

[Google Scholar]

Malviya N, Jain S, Gupta VB, Vyas S. Recent studies on aphrodisiac herbs for the management of male sexual dysfunction—a review. Acta Poloniae Pharmaceutica. 2011; 6: 3–8.

[Google Scholar]

Olawale F, Olofinsan K, Ogunyemi OM, Karigidi KO, Gyebi GA, Ibrahim IM, et al. Deciphering the therapeutic role of Kigelia africana fruit in erectile dysfunction through metabolite profiling and molecular modelling. Informatics in Medicine Unlocked. 2023; 37: 101190.

[Google Scholar]

Saikia Q, Adhikari K, Begum T, Dutta S, Hazarika A, Kalita JC. Erectile dysfunction: basics and its management using plant products. Egyptian Journal of Basic and Applied Sciences. 2024; 11: 25–41.

[Google Scholar]

Kyarimpa C, Nagawa CB, Omara T, Odongo S, Ssebugere P, Lugasi SO, et al. Medicinal plants used in the management of sexual dysfunction, infertility and improving virility in the east African community: a systematic review. Evidence-Based Complementary and Alternative Medicine. 2023; 2023: 6878852.

[Google Scholar]

Oloro J, Kihdze TJ, Katusiime B, Imanirampa L, Waako P, Bajunirwe F, et al. Phytochemical and efficacy study on four herbs used in erectile dysfunction: Mondia whiteii, Cola acuminata, Urtica massaica, and Tarenna graveolens. African Journal of Pharmacy and Pharmacology. 2016; 10: 785–790.

[Google Scholar]

Oketch-Rabah HA. Mondia whitei, a medicinal plant from Africa with aphrodisiac and antidepressant properties: a review. Journal of Dietary Supplements. 2012; 9: 272–284.

[Google Scholar]

Deeh PBD, Watcho P, Wang M. Ethnomedicinal, phytochemical, pharmacological and toxicological profile of Mondia whitei: a review. Fitoterapia. 2024; 177: 106119.

[Google Scholar]

Ng Y, Tang PC, Sham T, Lam W, Mok DK, Chan S. Semen Astragali Complanati: an ethnopharmacological, phytochemical and pharmacological review. Journal of Ethnopharmacology. 2014; 155: 39–53.

[Google Scholar]

Chen J, Zhu F, Pan M, Liu Q, Chen L, Tao Y. An emerging strategy for tracing the anti-erectile dysfunction components of raw and salt-processed semensof Astragali Complanati by combinatory liquid chromatography-mass spectrometry-based quantitative analysis, efficacy assessment on impotent rats, and partial least squares regression. Journal of Separation Science. 2022; 45: 1952–1959.

[Google Scholar]

Dassou GH, Favi GA, Salako KV, Ouachinou JM-S, Trekpo P, Akouete P, et al. An updated review of the African multipurpose tree species Detarium senegalense J.F.Gmel. (Fabaceae). South African Journal of Botany. 2023; 157: 525–539.

[Google Scholar]

Ejeje JN, Agbebi EA, Mathenjwa-Goqo MS, Oje OA, Agboinghale PE, Ebe IT, et al. Computational investigation of the therapeutic potential of detarium senegalense in the management of erectile dysfunction. International Journal of Molecular Sciences. 2024; 25: 12362.

[Google Scholar]

Ogunro OB, Yakubo MT. Fadogia agrestis (Schweinf. Ex Hiern) Ssem extract restores selected biomolecules of erectile dysfunction in the testicular and penile tissues of paroxetine‑treated wistar rats. Reproductive Sciences. 2023; 30: 690–700.

[Google Scholar]

Wattanathorn J, Pangphukiew P, Muchimapura S, Sripanidkulchai K, Sripanidkulchai B. Aphrodisiac activity of Kaempferia parviflora. American Journal of Agricultural and Biological Sciences. 2012; 7: 114–120.

[Google Scholar]

Zhang F, Xiong Y, Zhang Y, Wu K, Zhang B. Genetically proxied intestinal microbiota and risk of erectile dysfunction. Andrology. 2024; 12: 793–800.

[Google Scholar]

ZiuT, Liu X, Yang P, Ma Y, Gao P, Gao J, et al. The association between gut microbiota and erectile dysfunction. World Journal of Men’s Health. 2024; 42: 772–786.

[Google Scholar]

Omar MN, Norhanom AW, Norhayati I. Eurycoma longifolia Jack extract enhances sexual motivation in sexually naive male rats. Journal of Ethnopharmacology. 2012; 143: 531–535.

[Google Scholar]

Tan CSS, Lee SWH. Warfarin and food, herbs or dietary supplements interactions: a systematic review. British Journal of Clinical Pharmacology. 2021; 87: 352–374.

[Google Scholar]

Hsueh TH, Wu YT, Lin LC, Chiu AW, Lin CH, Tsai TH. Herb-drug interaction of Epimedium sagittatum (Sieb. et Zucc.) maxim extract on the pharmacokinetics of sildenafil in rats. Molecules. 2013; 18: 7323–7335.

[Google Scholar]

Roberge RJ, Kimball ET, Rossi J, Warren J. Clonidine and sleep apnea syndrome interaction: antagonism with yohimbine. Journal of Emergency Medicine. 1998; 16: 727–730.

[Google Scholar]

Ronis MJJ, Pedersen KB, Watt J. Adverse effects of nutraceuticals and dietary supplements. Annual Review of Pharmacology and Toxicology. 2018; 58: 583–601.

[Google Scholar]

Garg V. Facts about standardization of herbal medicine: a review. Journal of Chinese Integrative Medicine. 2012; 190: 1077–1083.

[Google Scholar]

Ahed M, Kumari S, Manakli P, Sonje S, Malik M. Safety and quality concerns regarding over-the-counter sexual enhancement products sold in USA market pose a major health risk. Journal of Addiction Research and Therapy. 2016; 7: 299.

[Google Scholar]

Yelehe-Okouma M, Pape E, Humbertjean L. Drug alteration of sexual enhancement supplements: a worldwide insidious public health threat. Fundamental & Clinical Pharmacology. 2021; 35: 792–807.

[Google Scholar]

Agarwal S, Charlesworth M, Elrakhawy M. How to write a narrative review. Anaesthesia. 2023; 78: 1162–1166.

[Google Scholar]